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PURPOSE AND SCOPE OF INVESTIGATION 
During the past fifty years, considerable attention has 
been directed to the part played by the blood platelets in 
the process of blood coagulation and to the significance of 
abnormal platelet counts in the clinical conditions classi-
fied as Hemorrhagic Diathesis (Spaet, 1952; Humble , 1949; 
McFarlane, 1941; Quick , 1951; Dameshek , 1955). Opinion has 
been growing steadily that the function of the blood platelets 
is maintenance of normal coagulability of blood by supplying 
the indispensible "thrombogenetic 11 elements as well as other 
platelet products (Quick, 1951; Tocantins , 1955; Whitby, 
1954; Maupin , 1955). It is also postulated (Spaet, 1952) 
that there may be another important factor, possibly vascular, 
in the pathogenesis of thrombocytopenic purpura. 
A method of producing experimental thrombocytopenic pur-
pura in the hamster (Mesocricetus auratus) is described for 
the first time in this thesis. It consists of the use of 
antiplatelet serum (obtained from the blood of rabbits fol-
lowing repeated injections of hamster platelets) to decrease 
the number of circulating platelets . Consequently , thrombo-
cytopenic purpura could be produced at will in hamsters for 
study of in vivo changes in the blood vessels of the everted 
cheek pouch in an effort to solve the physiopathology. The 
cheek pouch of the hamster has been in use by Fulton and Lutz 
since 1946 for studies of vascular changes in the living animal. 
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It is an excellent preparation for observations on the cir-
culation and for in vivo investigations of the formed elements 
of blood. 
'Ihe pathogenesis of hemostasis was investigated in immuno-
thrombocytopenia induced in hamsters by administration of anti-
platelet serum. The transparent cheek pouch was observed for 
long periods under the microscope and provided a direct ex-
perimental approach to the blood vessels. By means of ingenious 
tools such as microelectrodes , micromanipulators and cinephoto-
micrographic equipment, it was possible to observe and record 
significant in vivo changes. 
The recent discovery of a hemostatic defect produced by 
plasma expanders such as dextran and polyvinylpyrollidone 
(P.V. P . ) in man, as well as other toxic reactions, was respon-
sible for the initiation of studies on the possible purpuric 
effects of dextran in the hamster. 
It was the purpose of the work reported in this thesis 
to follow changes caused by dextran in the hamster and relate 
such changes to findings in immuno-thrombocytopenic purpura, 
in an effort to solve the riddle of the hemostatic defect 
that leads to purpuric hemorrhages or severe bleeding tenden-
cies in the diseases of man. 
REVIEW OF THE SCIENTIFIC LITERATURE 
A. Experimental Purpura 
In 1731, Petit in his classical writing introduced the 
physiological concept of hemostasis and expressedtt as the 
"gel that keeps a cut person from bleeding to death. 11 
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Since then, tremendous progress has been made in the field of 
coagulation of blood, and especially in hemostasis. With the 
increasing cooperation between the physiologists and physicians, 
radical changes have occurred and instead of the empirical 
treatment of a disease, a physiological and more scientific 
approach is being undertaken. 
Experimental work in the field of blood coagulation began 
as early as the 17th century with Malpighi. Since then, the 
well known discoveries of Hewson (1772), Buchanan (1845), 
Hammarsten (1877), Arthus and Pages (1890), and Howell (1928) 
have become classics in the history of coagulation. In the 
past century, the field has received new impetus with the avail-
ability of modern instrumentation and progress in physics, 
chemistry, physiology and clinical medicine. New advances 
have been made in research on platelets, prothrombin, fibrinogen, 
and thrombin. Information is now available from studies by 
direct observational techniques (Fulton and Lutz, 1941; Chambers 
and Zweifach, 1944). Clinical hematologists have recognized 
diseases accompanied by purpura in which bleeding is partially 
attributed to the platelets, although the critical decrease in 
number of platelets conducive to bleeding was not present. 
Platelets are said to have a triple role in hemostasis: 
coagulation, vasoconstriction and thrombus formation. 
(Quick, 1951). 
1. Antinlatelet Serum 
In 1907, Cole prepared antiplatelet serum by means of 
immunological procedures. He was trying to confirm the 
theory of Wright (1905) that the platelets originate from 
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the megakaryocytes of bone marrow, and not from the red blood 
cells as was believed by some observers (Kemp, 1907). In his 
ingenious experiments, Cole actually prepared two antisera in 
rabbits~ one against human red cells, and the other against 
platelets. The anti-red cell serum prepared from defibrinated 
blood did not agglutinate platelets in vitro, but exhibited a 
high hemolytic action in dilution of 1:600 against red cells. 
At the same time, the antiplatelet serum (APS), prepared in a 
manner very similar to present day methods did agglutinate the 
platelets, but not the red cells. This was perhaps the first 
experimental production of antiplatelet serum, using repeated 
injections of human platelets into the rabbit. LeSourd and 
Pagniez (1907) injected animals intravenously with APS and ob-
tained results similar to vascular purpura, with a rapid dis-
appearance of platelets from the circulation and failure of 
the clot to retract. Their observations were confirmed by 
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Achard and Aynaud. (1908) Ledingham (1914) demonstrated that 
antiplatelet serum in high dilutions would agglutinate platelets 
in vitro, and that the lesions produced by injection were 
typical of purpura hemorrhagica in man. This was confirmed in 
guinea pigs by Lee and Robertson (1916) who also concluded 
that antiplatelet serum had no local effe~t and that the serum 
of guinea pigs suffering from severe experimental purpura had 
no effect on p latelets in vitro or in vivo. More recently, 
Troland and Lee (1938) produced thrombocytopenic purpura in 
rabbits with an extract from the spleen of human patients with 
thrombocytopenic purpura. 
Various observers (Bedson, 1915; Lee and Robertson, 1916) 
have tried to study the effect of antiplatelet serum in vitro 
or in the whole blood of different animals. All the results 
uniformly agree that antiplatelet serum has a strong aggluti-
nating and lytic effect on the platelets and that the action 
is specific. If the serum is not absorbed by incubation with 
fresh red cells, the red cell clumping will occur. 
If antiplatelet serum is given subcutaneously, thrombo-
penia and purpura result, depending upon the dose of anti-
platelet serum. The onset of symptoms is gradual. A "full 
blown" picture of purpura hemorrhagica, as described in the 
following discussion, develops only with a large dose or re-
peated administration of the anti-serum. The effects on the 
blood and the other tissues are similar to those caused by 
intravenous administration. 
Intraperitoneal injection causes similar effects. The 
local site of parenteral injection exhibits a purpurogenic 
response. The phenomenon of experimental purpura resulting 
from subcutaneous or intraperitoneal injection of antiplatelet 
serum is reversible if the dose is not too large. 
The intravenous administration of antiplatelet serum in 
large doses produces death of the animal either immediately 
or within a few hours, accompanied by precipitous platelet 
decrease and manifestations of hemorrhage in most of the in-
ternal organs. Very small doses have milder effects and may 
be reversible . 
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\Vhen antiplatelet serum is injected subcutaneously, 
intraperitoneally or intravenously in guinea pigs, rabbits, 
rats, mice, dogs and hamsters, purpuric lesions occur in various 
organs, associated with decreased platelet counts. The lesions 
subsequent to use of the intravenous or intracardiac route are 
more consta nt and uniform (Tocantins, 1939). The site of in-
jection acquires a variable degree of ecchymosis. The skin and 
mucous membranes in various parts of the body show an irregular 
distribution of petechiae and ecchymoses, depending upon the 
potency of the serum and the dosage. If the dose is moderate, 
the acute attack of purpura lasts for about 48 hours and the 
changes are reversible (Ledingham, 1915; Tocantins, 1939). 
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The injection of antiplatelet serum is followed by a fall 
in platelets and the simultaneous appearance of purpura. The 
decrease in platelets is acute with a potent dose and may pro-
ceed to complete disappearance of platelets from the circulation. 
The red cells and white cells are in general not affected. The 
peripheral blood smear shows variable degrees of anisocytosis, 
poikilocytosis and numerous polychromatophilia. No other ab-
normalities of red cells or leukocytes are seen. 
The bone marrow exhibits inconsistent changes in guinea 
pigs (Ledingham, 1915; Lee and Robertson, 1916). The mega-
karyocytes possess pyknotic nuclei, and an occasional shrunken 
appearance is seen. In dogs, Tocantins and Stewart (1939) 
showed tha t the megakaryocytes of the marrow and tissues possess 
degenerative changes. 
Various tissues of the body exhibited histological changes 
varying from marked inflamma tory response s to hemorrhage and 
necrosis. Pancreas, adrenal, thymus, muscle, bra in, liver, 
spleen, gastrointestinal tract, and genitourinary tract were 
hemorrhagic and showed changes due to cytotoxicity of the serum. 
Cataract has been ob served (Bedson and Ledingham, 1916) in 
animals even after subcutaneous injection of serum. 
Although antiplatelet sera have been in use experimentally 
since 1907 (Cole), our knowledge is still far from complete. 
The following facts have been summarized (Chevrel and Roger , 
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1907; Cole, 1907; Aynaud, 1911; Bedson et al, 1915 and 1921). 
1 . Antiplatelet sera are species specific. 
2. Antiplatelet s e ra agglutinate or lyse platelets in vitro. 
3. The exact mode of action and role in hemorrhage is not 
known. 
4. In vivo, specificity is relative. 
5. Red cells and white cells are not affected. 
6 . Platelet antibody per se results in purpura and the 
phenomenon is independent of hemagglutination. 
7. A temporary reduction of platelet s per se by other means 
does not lead to purpura . 
8 . It is postulated that two factors may be responsible for 
hemorrhages produced by antiplatelet serum: first, toxic 
action on the endothelium; and second , thrombocytopenia. 
In summary, antiplatelet serum has been used for the 
following purposes. 
1. Cole in 1907 used antiplatelet serum to study the pro-
duction of platelets from megakaryocytes and opposed the theory 
that platelets are produced from red blood cells. 
2. Antiplatelet serum has been used to study the etiology 
and pathology of experimentally-induced purpura (Ledingham, 
1915; Bedson, 1915; Lee and Robertson 1916; and Tocantins, 1936). 
The purpura so caused is similar to that seen in man, charac-
terized by a decrease in p latelet count as well as purpuric 
lesions in the body. 
3. Ledingham (1914) worked with antiplatelet serum to 
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determine whether phagocytizad platelets may simulate any other 
cell inclusions. In the presence of human anti platelet serum 
prepared in rabbits, the phagocytosis did take place, but the 
serum was not very powerful. 
4. Antiplatelet serum has been used for the production of 
an anaphylactoid shock. It is considered by Cruz and DeSilva 
(1949) as the most powerful tool for this purpose . The ana-
phylaxis-like reactions are caused because of abrupt removal 
of circulating platelets by the specific serum. It has been 
postulated that a common basic mechanism exists in thrombo-
cytopenic purpura and anaphylactic , tryptic or peptonic shocks. 
For an understanding of the pathogenesis of thrombocyto-
penic purpura in human beings , it might be worth reviewing the 
observations recorded in the literature concerning a thrombo-
cytopenic factor present in human blood. Harrington et al 
(1951), Stefanini et al (1952), and Kissmeyer-Nielson (1953 ) 
ha~e observed that injection of the blood pf patients with 
thrombocytopenic purpura (idiopathic) into subjects with normal 
platelet counts resulted in lowered platelet numbers. Similar 
observations have been made by Mushett et al (1953), that normal 
human, dog, and sheep pla.sma or sera contain anti-rabbit platelet 
and erythrocyte factors which produce thrombocytopenia and anemia 
following an intravenous injection. These factors have been 
studied in detail. They are stable to heat, but labile to aging . 
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The factors can be separated from the plasma by the same chemical 
means for the removal of prothrombin. They are present in the 
g lobulin fraction of the serum proteins. The steroid hormones 
such as ACTH and cortisone and also splenectomy have no counter-
a cting effects on this factor. 
2. Splenectomy 
Bedson (1925) postulated that the large number of platelets 
found in the spleen might be explained either by production of 
these elements or by collection in this organ for the purposes 
of destruction. Evidence against the hypothesis that platelets 
are produced in the ~leen was presented by Hess (1917) who re-
ported that splenectomy was followed by increase in the number 
of platelets in the circulating blood. Similar observations 
were made by Crawford (1925), and since then splenectomy has 
become a mode of treatment for purpura hemorrhagica. Recent 
observations made in man (Desai, 1955) indicate a definite 
platelet rise postoperatively in splenectomized patients, 
frequently for long periods. Bedson (1924) observed a rise in 
platelets in guinea pigs at 48 hours, becoming maximal at the 
tenth day to fourteenth day and returning to p~eoperative 
values after 3 to 4 weeks. 
When splenectomized guinea pigs were given antiplatelet 
serum, the platelet count decreased but purpura did not occur. 
Presumably splenectomy offered a certain degree of protection 
against the production of purpura by means of antiplatelet 
serum and the spleen is indirectly concerned in the pathogenesis 
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of purpura. However, splenectomy cannot be relied upon to give 
more than temporary relie f in the treatment of hemorrhagic purpura. 
3. Other Methods for Producing Purpura 
Early attempts to produce thrombocytopenic purpura experi-
mentally have been made by several means, utilizing agents such 
as benzene, diphtheria toxin (Duke, 1911; Reimann, 1926; Shih, 
1931), pneumococcus extrac t, and thorium (Gottlieb, 1919; Lee, 
1916). These substances were not of much use for evaluation of 
the pathogenesis of the hemorrhages prevalent in purpura. 
Moreover, certain substances produce a reduction in platelet 
count without the purpura . Examples are saponin, colloidal 
suspensions of silver and arsenic , egg albumin, lecithin , acacia, 
peptone and some vegetable and mineral oils (Tocantins, 1936). 
Myelosuppressive agents, such as triethylene melamine and nitro-
gen mustard, used for the treatment or the control of leukemia 
and allied disorders also cause a drop in platelet counts. 
Among all these purpurogenic agents , the antiplatelet serum is 
specific and causes purpura with a decrease in platelet counts 
and concomittant hemorrhagic phenomena. Various species have 
been used in the study of the effects of antiplatelet serum, 
for example, guinea pig, rat, rabbit, mouse, and dog (Bedson, 
1914; Ledingham, 1915; Lee and Robertson, 1916; Tocantins, 
1936). In the present investigation, hamsters have been utilized. 
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4. In Vivo Observations of Blood Vessels in Experimental Purpura 
Direct microscopic observations of small blood vessels in 
experimental purpura are lacking except for the work of Spaet 
(1952) in the mesoappendix of the rat after injection of anti-
platelet serum. No morphological evidence of vascular alter-
ations was found in the group treated with antiplatelet serum. 
B. Dextran 
It is beyond the scope of this thesis to review the entire 
literature on dextrans since no less than a thousand or more 
references have been published on this subject. Only the most 
pertinent references have been reviewed. 
Blood is recognized as the only satisfactory substitute 
fluid in cases of shock due to hemorrhage. However, the dif-
ficulties in obtaining donors during emergency, the problems 
of typ ing and cross-matching, and the possibility of trans-
ferring infectious diseases are well known. Attempts have 
been made during the past forty years to find an ideal substitute 
fluid that would help to maintain plasma volume in shock due to 
massive hemorrhage. Since 1906 when Morawitz first described 
gum acacia, the medical literature has been full of accounts 
of such possible plasma substitutes. An extensive trial of gum 
acacia was unsuccessful during the first World War, because of 
undesirable reactions and stor~ge in liver and other body tissues. 
In l915, gelatin and derivatives were used as plasma expanders 
for treatment of shock. This resulted in the abnormal histo-
logical findings of foam cells in the liver, as well as the 
associated detrimental effects. 
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During World War II, polyvinylpyrrolidone (P.V. P .) was 
extensively used by German physicians, but the results have 
been controversial. Using radioactive P .V.P., VanSlyke (1951) 
studied the metabolism and found no abnormal accumulation in 
the liver. On the other hand, Fine (1951) stated that con-
centration occurred in liver and spleen to about five times 
that found elsewhere. Because of the s e confusing reports, 
the use of P.V.P. has been confined to the laboratory, and its 
clinical application has not been encouraged . Other animal 
and vegetable products investigated in the pas t are globin 
solutions (Strumia, 1946), ascitic fluid (Davis, 1938), 
casein digests (Hissink, 1950), methyl cellulose (Hueper, 1942), 
and okra (Benjamin, 1951). All are in either an experimental 
status or ha ve been discarded because of possible toxicity. 
In recent years, dextran solutions of various molecular 
sizes have been commonl y used in the sea rch for plasma sub-
stitutes, particularly since World War II. Dextran was first 
described by Schleiber, a German sugar chemi s t, who noticed a 
mucous-like substance tha t occurred in the sugar refining proce ss . 
The present-day dextrans are a group of macromolecular substances, 
produced fro m sucrose by the action of a contaminating non-
pathogenic micro-organism, Leuconostic mesenteroides. Groenwall 
and Ing leman in 1941 cultivated this organism and produced 
dextran from the resulting fermentation of sucrose. 
1. Relative Importance of Molecular Size 
The native, high polymer dextran is extremely toxic, but 
after acid hydrolysis to a suitable molecular weight range, 
it is suitable for intravenous use in humans. Thus, the mol-
ecular weight is an important factor in the efficacy of the 
substance as a plasma substitute. The American dextrans have 
an average molecular weight of about 72,000. 
Dextran is generally administered as a six per cent 
solution in physiological saline. The viscosity and the 
colloidal pressure are similar to those of plasma. If a 
dextran solution heterogeneous in molecular size is introduced 
into the circulation, a biological fractionation takes place. 
Small molecules leave the circulation relatively rapidly and 
large molecules more slowly. Small molecules of dextran leave 
the blood vessels, enter the interstitial spaces, and become 
excreted in the urine. The large molecules may remain in the 
plasma. If the solution contains predominantly large molecules, 
the plasma volume expansion will be maximum, and fluid will be 
withdrawn from the tissues and taken into the blood, provided 
that leakage is slower than that of blood proteins (Was serman, 
1954). How far the retention of large molecules and ultimate 
metabolism are detrimental to the body, a re very important 
questions concerning a plasma expander. 
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2 . Fate of Dextran in Human Body 
Following intravenous administration, dextran is excreted 
primarily in the urine. Only a minute amount appears in the 
gastrointestinal tract. The rate of urinary excretion varies 
with the size of the dextran molecule. Ingleman in 1941 
stated that the Swedish dextran (average M.W. 34,000) is com-
pletely cleared from the blood within 5 days after injection. 
Other reports in the literature state that 20 to 25 per cent 
of the amount injected is excreted in the urine during the first 
25 minutes (Turner, 1949{ Thorsen, 1947; Bull, 1949). Using 
intravenously administered radioactive dextran with a half life 
of 6.1 days, Hellman and Becker (1952) and Terry and Yuile 
(1952), showed that 60 to 65 per cent appeared in the urine 
within the first 10 days and tha t approximately 25 per cent was 
metabolized in the body and expired as carbon dioxide. This 
accounts for the overall fate of dextran in the human body, 
although the complete metabolism is still not understood. 
3. Detrimental reactions 
The hemodilution resulting from dextran infusions produces 
a decrease in red cell counts, hematocrit values, and total 
plasma protein concentration. There is a transient increase 
in cardia c output, stroke volume, and in arterial and venous 
pressures as reported by Witham in 1951. These changes are 
temporary and reversible. 
16 
Undesirable reactions such as urticaria, itching, joint 
pains, headaches, vasomotor collapse, respiratory distress, 
evacuation of bowels, have been observed by many authors in 
varying degrees of severity (Wilkinson, 1953; Thorsen, 1949; 
Pulaski, 1951; Bloom, 1951). Kabat and Berg (1953) reported 
an antigenic effect of dextrans in man. Maurer (1953) re-
viewed the literature on antigenicity of dextrans and confirmed 
the antigenic effect in man. Antibodies produced after im-
munization with dextran are specific for dextran. 
In 1950, Thorsen determined the percentage of detrimental 
reactions to dextran in Sweden. In over 30,000 cases, the re-
actions occurred in 0.8 per cent of the patients. In England, 
a survey by the Medical Research Council of approximately 
1600 subjects who had received dextran, revealed reactions in 
1.88 per cent (Maycock, 1952). Healthy American volunteers 
were given the Swedish dextran and developed a very high per-
centage of reactions reported as 40 per cent (Gropper, 1952; 
Pulaski, 1952). It should be noted that the same material was 
used in Sweden end the reactions were trivial. It was found 
subsequently that the reactions could be minimized if anesthesia 
were used. 
A previously undescribed hemostatic defect in man after 
dextran infusions was described by Carbone et al (1954). The 
defect is characterized primarily by a prolonged bleeding 
time after an infusion of 1000 ml to 6000 ml of 6 per cent 
dextran. The change s that occurred in the blood coagulation 
mechanism were minor and their investigatiQn did not reveal 
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any logical explanation of the underlying defect. More re-
cently Adelson a nd Crosby (1955) have studied the problem in 
dogs infused with dextran and have postulated that the bleeding 
phenomenon may involve either a platelet deficiency or a defect 
in the vessel wall. 
4. In Vivo Observation of the Blood Vessels after Dextran Infusion 
Hueper (1943) was among the first to describe gros s changes 
tha t occurred in blood after the injection of macro-molecular sub-
stances. He called the effects "Hematic syndrome", characterized 
by transitory leukopenia and subsequent leukocytosis of con-
siderable degree. 
Vejlens in 1938 described the microscopic changes in the 
mesentery of guinea pigs and rabbits after the injection of 
macro-molecular substances and reported white cell sticking to 
the end othelium of ve s sel walls and leukopenia in the peripheral 
blood. Greenwell and Ingleman (1945) were the first to use 
dextrans in animal experiments. They ob s erved a great increase 
in sedimentation rate, but completely missed the observation of 
increased sticking of white cells. Squire (1951) stated that 
dextran does not cause leukocytic adhesions to the endothelium. 
Leusen and Essex (1953) showed that white cell sticking is pre-
dominent in blood ves s els in rabbit ear chambers after dextran 
infusions, as well as transitory leukopenia in peripheral blood. 
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MATERIALS AND METHODS 
A. Hamster Cheek t>ouch _ Technique 
Hamsters of either sex, varying from 5 to 10 weeks 
of age and weighing 75 to 100 gramsrwere used throughout the 
investigation unless mentioned otherwise. The animals were 
anesthetized with 6.5 per cent Nembutal (Pentobarbitol Sodium, 
Abbott). A dose of 0.15 ml per 100 gram body weight was used 
intraperitoneally with fortification by 0.5 ml increments as 
needed . 
The cheek pouch of the hamster was prepared for ob-
servation of the blood vessels according to the method of 
Fulton, Jackson, and Lutz (1947). The anesthetized hamster 
was placed on a plastic animal d i sh (Fig. 1) specially made 
for observations on the cheek pouch . The pouch was everted 
by gentle traction with forceps a nd pinned on the supporting 
rubber block in the plastic dish (F i g . lA). Transillumination 
was accomplished through a transparent window under the cheek 
pouch. The moat in the hamster dish was filled with mammalian 
Ringer ' s solution in order to keep the pouch moist and main-
tain physiological conditions. For routine use, the cheek 
pouch was studied as a double-layered membrane . For photo-
graphy and micromanipulation, a single membrane preparation 
was made by cutting a small circular flap in the upner wall of 
the pouch, in an area selectively devoid of large blood vessels. 
The connective tissue was removed to ensure a uniform trans-
parency of the layer underneath. In a "normal" pouch, the 
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bleeding usually encountered during the minor surgical pro-
cedure was self-controlled, while in certain experimental 
groupsof hamsters exhibiting hemorrhagic tendencies, the 
bleeding was controlled by heated micropins, applied carefully 
to the bleeding sites. 
The transilluminated cheek pouch of the hamster is 
an excellent membrane which can be exposed readily and kept 
under observation without major surgical procedure. In fact, 
the cheek pouch may be characterized as a living microscopic 
laboratory. This preparetion has been very useful in the 
present investigation of experimental purpura and the effects 
of dextran infusion. Furthermore, it provides a challenging 
method for future use in physiological investigations in the 
field of microcirculatory research and in vivo hematology. 
B. Hernatologlcal procedures 
Small quantities of blood were obtained from the 
tail or the paw of the anesthetized hamster by means of a 
stab wound with the tip of a Bard Parker blade (number 11). 
When larger amounts were needed (0.5 to 2 ml), cardiac puncture 
was accomplished by means of a syringe with number 25 B. D. 
needle (3/8"). Light anesthesia was used for cardiac puncture. 
Red cell counts, white cell counts, and differential 
counts (Fig. 2) were made by routine standard techniques. The 
platelet counts and reticulocyte counts were performed by the 
method of Dameshek (1932). Hemoglobin determinations were made 
with a spectrophotometer. 
Bleeding time determinations were done by the 
following technique. A stab wound was made in the skin of 
the tail, producing an incision 1 rnm. long and 1 mrn. deep. 
The blood was blotted at regular intervals with a filter 
paper . The normal bleeding time was 109 + 19 seconds in 
hamsters of both sexes, weighing 75 to 100 grams (Fig. 3). 
Whenever the bleeding time was more than 240 seconds, the 
observation was discontinued and a piece of rubber elastic 
was tied to insure hemostasis. This precaution was taken 
since 1 to 2 ml of blood may be lost in this way if the 
hamster has an abnormal bleeding time. Repeated bleeding 
times were determined very easily on the tall by this tech-
nique. 
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Coagulation times were performed by a modification 
of the method described by Lee and White (1913). Exactly 
0.15 ml of blood was collected by cardiac puncture and placed 
in 5 x 70 mm. tubes maintained at a constant temperature of 
37° C . in a thermostatically controlled water bath. The 
tubes were tilted every 15 seconds until a clot was formed. 
The interval of time between collection of blood in the syringe 
and clot formation in the tubes, measured by a stop watch, was 
recorded as the coagulation time. The coagulation time was 
143 + 50 seconds in "normal" hamsters. Determination of pro-
thrombin times were made by means of the procedure described 
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by Quick (1951). The prothrombin time was 10.5 + 0.2 seconds. 
Clot retraction was estimated by the routine method (~uick, 
1951). After one hour, the extracted serum was measured in 
normal and abnormal hamsters. The fibrinolysis test was done 
as a screening procedure to see if there were gross abnorm-
alities in this phase of the coagulation process . The clot 
was inspected for lysis during 24 hours. 
Bone marrow studies were ma.de by the following 
technique . The hamster was sacrificed, the femora were 
separated from their attachments, and the covering muscle and 
connective tissue were removed. The bone was then split lon-
gitudinally , very carefully, by means of a thin pair of 
scissors. The marrow was scooped out on a few clean slides 
and spread by means of a two-slide technique. The slides were 
then stained with Wright and Giemsa solutions. Sufficient 
marrow was obtained to make three or four slides from each 
bone. This is an advantageous way to collect marrow since the 
problem of dilution with blood does not arise as it happens in 
bone marrow aspirations . 
C. In ivo Tests for Vascular Fragility 
The mocce ·sln snake venom test was used as an index 
of hemorrhagic tendency and a measure of vascular fragility 
(Arendt et a.l, 1953). A fresh solution of venom (1%) was 
prepared in small amounts and diluted with one thousand parts 
of mammalian Ringer's solution. A standard amount of venom 
(0.02 ml) was injected between the layers of the tbin trans-
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parent portion of the pouch (Fig. 5) under a dissecting micro-
scope. The pouch was kept moist by means of a saline cotton 
pad a pp lied to the injected site. A small bleb was produced 
by the injection. Observations were made at half-hour intervals 
for two hours, and the number of petechiae were counted. The 
anticipated count for a normal hamster is 150 petechiae at the 
end of a two hour interval (Fulton et al, 1955). In accordance 
with the state of the hamster, the petechiae produced by moc-
casin venom differ in number, size and shape. The test has 
been applied to x-irrediated,. cortisone-treated, and Adrenosem-
treated hamsters as a screening procedure for antihemorrhagic 
agents (Fulton et al, 1955). 
The negative pressure test (Fig . 6) was used to produce 
petechiae in the cheek pouch . A bell-shaped suction ·cup 
(half an inch in diameter) was connected to a calibrated 
suction pump. The cup was held tightly against the cheek 
pouch and suction was applied by operation of the pumu. A 
negative pressure of 20 centimeters of mercury was nroduced 
for exactly one minute, using a stop watch. The cheek pouch 
was examined before and after application of negative pressure, 
and the petechiae were counted. In normal hamsters, 0 to 4 
petechiae were produced, but the numbers were increased in 
pathological states. 
The microelectrode test was used as an additional index for 
changes in vascular fragility. Silver-glass microelectrodes were 
made as described by Fulton (1941), using surgice l suture wire 
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(silver, # 28) threaded into a glass capillary tube. The elec-
trades were pulled ca refully in a flame from a microburner. 
Suitable electrodes were 1 to 5 microns in size at the tip and 
electrolytica lly active upon testing . ~he unipdar stimulating 
electrode was adjusted on a micromanipulator (Emerson Company), 
the microelectrode tip was placed in contact with the wall of 
the blood vessel, and an indifferent electrode was placed in 
the circuit. Stimulating currents were produced by means of a 
Gros s electronic stimulator (P- 4,). The microelectrode was 
tested initially a t low voltage in order to determine the 
"bubble threshold" (usua lly 1.5 to 3 volts). The bubbles, 
consisting of hydrogen gas , are by-products of ,electrolysis 
I ' and indicate that the electrode is conducting current. Single 
shocks of increas ing intensity were given to determine i hbe 
threshold in volts required to produce vascoconstriction of 
vessels of measured diameters, the threshold for white cell or 
thrombus formation, and that required to produce rupture of 
the ves sel wall and hemorrhage. Normal venules and a rterioles 
were very resistant to rupture even a t 150 volts. Occasionally 
a normal vessel ruptur ed suddenly at 150 volts and beca me 
sealed instantaneous at both ends, without bleeding . Th~s 
phenomenon has been described as "electrocoagulation". In 
pathological states, or after treatment with antiplatelet 
serum, the threshold for fragility of the vessel wall was 
lowered and bleeding ensued at low voltages. This procedure 
is a semi - quantitative test of the vessel wa ll fragility. 
24 
D. Production of Immunothrombocytopenic Purpura 
Hamsters of both sexes weighing 150 i 20 grams were 
used as sources of blood for obtaining platelets . The blood 
from the hamsters was pooled . Clean, siliconized glassware 
(syringes and tubes) were used for the separation of platelets . 
Blood was drawn from anesthetized hamsters by cardiac puncture 
and collected in equal volumes of physiological Sequestrene . * 
Centrifugation was accomplished in siliconized tubes at 1000 
revolutions per minute for 10 minutes . The supernatent 
platelet-rich fluid was separated in siliconized tubes and spun 
down at 3000 , revolutions p er minute for half an hour. At this 
speed, the platelets settled in the form of a 11 button 11 and the 
supet:"natent fluid was discarded. The platelets were uniformly 
suspended in 3.0 ml of physiological saline by gentle tapping 
of the tube for several minutes. Half a milliliter of this 
platelet suspensio~ was injected intravenously (ear vein) into 
each of 6 rabbits every week for six successive weeks . After 
a rest period of one week , a booster dose of one milliliter of 
the platelet-rich suspension (freshly prepared) was given to 
each rabbit and 40~50 ml of blood were collected after an in-
terval of one week from the last injection. Blood was allowed 
to clot and the serum obtained was inactivated at 56° C. for 
half an hour. It was absorbed with an equal amount of washed 
red cells procured from hamsters. The mixture was centrifuged 
at 3000 revolutions per minute for half a n hour, and the super-
natent serum was prepared for the experiments. This serum is 
* Sequestrene disodium , 1.0 gm; sodium chloride, 0 .7 gm; 
distilled water , 100 cc. Solution refrigerated and 
filtered before use. 
a.nti-hamster platelet serum (derived from rabbit blood) and 
will be referred to as 11 a ntiplatelet serum 11 or APS . It may 
be stored in the deep freeze for a long time without loss of 
~otency. The potency was established by means of standard 
immunological titration techniques, a nd an average potency 
value of 1:512 was maintained throughout the experiments. 
An intravenous dose of 2 .5 ml produced death in the hamster 
within twelve hours. Lower doses of 0.5 to 2.0 ml resulted 
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in varying degrees of generalized bleeding. When addit ional 
serum was needed , the same rabbits were injected with platelet 
suspension once or twice a week and ~-Jere bl:eo after one week of 
rest. Then the antiplatelet serum was prepared as described 
above. 
E . Snlenectomy 
The anesthetized hamster was placed on a dissecting 
board in the ventral position, a.nd the left epigastric a.rea 
was sterilized by tincture of iodine. An incision one inch 
in length was made in the skin at the left of the midline , 
just below the costal marg in a nd deepened to the fascial layer. 
The peritoneum was lifted by forceps, carefully nicked, and en-
larged to the size of the skin incision. If necessary, bleeding 
was controlled by hemostats or cotton threa.d ligatures. The 
spleen is situated on the left side below the stomach. It was 
exposed by means of forceps, and reflected on the surface of a 
piece of clean gauze. The primary blood vessels supply the 
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spleen at the superior, middle and inferior margins respectively. 
These were gripped withremostats , ligated, and cut, freeing the 
spleen from the ped icle for easy removal. The gastric br8nches 
of the vascular supply to the spleen were often difficult to 
ligate . After thorough hemostasis, the peritoneum, musculo-
fascial layer, and the skin were sutured separately and the wound 
was sterilized again. The healing was perfect and no mortality 
or complication occurred in hamsters if p roper precautions were 
taken. No expe riments were done for at least 2 days a fter t he 
oper a tion. The usual labora tory diet and fluids were g iven to 
these animals. 
F . Femoral Cannulation Te chhique for Intravenous Infusions 
The anesthetized hamster was placed on a dissecting 
board in the ventral pos ition , the hair was shaved from the 
femora l are~ , and the skin was sterilized . A short horiaontal 
incision (1 to 1.5 em) was made par a llel to the course of the 
femoral ves sels and extended to the f ascio-muscula r l ayer. Under 
a dissecting microscope , the muscle gap was widened without major 
bleeding or cutting . The femoral vein was exposed and two liga -
tures were fixed in position for cannulation. An intrade rmi c 
polyethylene tub ing (P-10, Clay Adam s & Co .) 4 to 5 inches in 
length was filled with mammal i an Ringer's solution . The distal 
end of the vein was ligated, a nic~ was made , and the poly-
ethylene tube was inserted and tied. The patency of the tube 
wa s checked by the application of a syringe with a number 27 
needle and the free end closed temporarily by means of heated 
forceps (Fig . 7). Slow injection was utilized. 
G. Cinephotomicrographic Re cording 
Cinephotomicrographic records of vascular changes in 
the hamster cheek pouch were made by techniques previously 
?~ 
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described (Fulton, et al, 1941, 1953, 1954; Lutz, et al, 1951). 
Hematological studies in vivo have been recorded by this 
technique under magnifications from 200 X to 1800 X (Fulton, 
Lutz, Desai, a nd Berman, 1954). Several film sequences 
demonstrate the use of the cheek pouch for evaluation of 
in vivo effects of plasma expanders (Dextran). 
RESULTS 
Hematologica l Findings 
A. Normal Hamsters 
2 
Forty-four hamsters of either sex , weighing between 75 
a nd 100 g rams , were u s ed for comp lete blood determinations. The 
blood was obtained fro m the tail or by cardiac puncture. The 
formed elements were counted, a nd the r esults (Table I) were 
analyzed statistically (Fish er, 1950). The red cell counts 
were 6.8 i 1.2 million pe r cubic millimeter . The white cells 
aver aged 5 .7 2 i 1 .5 thousand per cubic millimeter , and the 
p latelet s were 8 .1 { 1.1 million per cubic millimeter. The 
hemoglob in was 15.8 L 2~1 gm. pe r cent as estima ted by the 
photoelectric method (Cole). Th e reticulocy te values were 
2 . 5 L 1.2 per cent. The differential va lues for white blood 
cells were ca lculated from counts of 200 cells. The following 
results were obta ined : polymorphs, 30 L 6 pe r cent; l ymphocy tes, 
61 i 7 . 5 pe r cent; monocytes , 3 i 0. 5 pe r cent; and eosinophils, 
1.2 i 1.0 per cent. No basophils or unidentifiable cells were 
seen . 
The smears of peripheral blood (Fig . 2) from normal ham-
sters showed slight differences in red cell morphology as 
compared with human blood smears . The red cells ha d the same 
diameter as tha t of human red cells, but va ried slightly i n 
shape. Slight anisocytosis, slight po ikilocytosis, and a 
certa in degree of polychromatophilia we r e seen consisten tly. 
Occas ional target cells but no spherocytes were present on t he 
smear . The p latelets were similar to those of man , separate, 
and not clumped ( F i g . 1 2 ). The po lymorphonuclea r cell had 
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somewhat greater lobulat ion that that of normal healthy man. 
The degree of lobulation varied from 5 to 8 lobes with oc-
casionally 8 to 10. Non-filamentous forms a nd doughnut-shap ed 
cells were a lso present among the granulocytes. These finding s 
do not deviate markedly from those reported by other workers 
(Steaart et e l, 1944; Rose et a l, 1945; Ga rdner, 1947; Crabb 
and Kelsall, 1951; Otis et al, 1952; and Sherman, 1953). 
Reticulocyte counts were made a nd reported for the first 
time in the h Emster, averaging 2.5 i 1.2 per· cent. Tb1s value is 
slightly higher than that obtained ln human subjects, probably 
indica ting a rapid formation of red blood cells end maintenance 
of a high norma.l red cell count as oompared with man. The 
platelet and reticulocyte counts were done by the method of 
Dameshek (1932), a nd the p latelet values are higher than those 
reported previously. However , indirect counting techniques 
always yield values approxima tely t wice as high as those with 
d irect techniques. 
Bone Marrow Examination 
The app earance of the bone marrow of the normal hamster 
is shown in Figure 4 . The preparation is rather cellular as 
compared with tha t of human mar row , perhaps beca use of the 
technique used in the hamster. Also, the ratio of white cells 
to red cells is approxima tely 8 to 1 as compared with a r a tio 
of 4 or 2 to 1 in man. The megakaryocytes a re more numerous 
per fie ] a than in human marrow but the proportional numbers 
a re similar . The megakaryocytes as seen in hamsters a re very 
similar in size, shape and morphology to those of human sub-
jects (Fig. 12). The white blood cells . are similar to those 
in human marrow with respect to maturation . The lymphocytes 
are infrequent. The erythrocytic cells are normal in number 
and maturation. Occasional reticulum cells and mast cells 
are seen. Sherman (1953) reported similar bone marrow values 
in the hamster . 
Coagulation Factors 
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Coagulation times (Table 2) were taken in 15 normal ham-
sters . The average value of 143 i 50 seconds was similar to that 
reported by Akers (1951). 
Bleeding times (Table 3) were done in 36 hamsters of either 
sex. Average values of 109 i 19 seconds were obtained by the 
filter paper method (Fig. 3). Akers (1951) recorded bleeding 
times in normal hamsters and those with anticoagulants , using 
the cheek pouch as the site of observation. However, the filter 
paper technique has not been employed which provides a record of 
the bleeding time in the form ,of a measurable blot (Fig. 3). 
The prothrombin times were determined in 6 normal hamsters 
( Table 4). The average value of 10.5 i 0.2 seconds is in agree-
ment with that reported by Akers (1951). 
The clot retraction tests were made on 5 ml of blood ob-
tained by cardiac puncture . Screen controls were used in the 
experiment. The serum was measured accurately after one hour, 
a nd 0.26 i -0 .11 ml were obtained in normal hamsters (Table 5) . 
:l 
A test for fibrinolysis was done by observing 2 ml of clotted 
blood in a glass tube at 24 hours. Lysis was not observed and 
hence the test was taken as normal. 
Tests for Vascular Fragility and Hemostatic Function 
The negative pressure test (Fig. 6) was applied to the 
hamster cheek pouch using the method described by Shulman, 
et al (1953). In normal hamsters, 0 to 4 petechiae were 
formed in the pouch after application of negative pressure for 
one minute. The snake venom test (Fig. 5) was done on 33 nor-
mal hamsters . A total of 71 l 6 petechiae (Fig . 13) were counted 
at one hour, and 138 l 20 at 2 hours (Table 6). 
The microelectrode test for vascular fragility and hemo-
static function was applied to two group s of normal hamsters of 
either sex: first, young animals weighing 75 to 100 grams; and 
second, an "old age 11 g roup weighing 150 l 20 grams . The re-
sults were essentially similar in both groups, and no effect 
of agining on fragility was demonstrable by this method. Micro-
electrodes were used to stimulate the ~alls of blood vessels 
varying in size from 25 to 160 microns. The results in normal 
hamsters are shown in Table 7 . The vessels were arbitrarily 
g r aded into t hree sizes: small (30 L 5 microns in diameter), 
medium (75 l 7 microns), and large (150 i 10 microns) . 
Microelectrodes were first tested for conductivity with low 
voltages of 1.5 to 3 volts ("bubble threshold"). The formation 
of a bubble at the electrode tip indicated suitability (Fig . 9). 
By means of a micromanipulator, the electrode w~s pl ~ ced on the 
wall of the vessel, and the voltage required to produce a 
constriction of the vessel was determined (threshold for con-
striction, Fig. 10). The voltage was increa sed until a thrombus 
formed a t the site of stimulation (thrombus threshold) . The 
voltages were increa sed to determine the threshold for rupture 
of the vessel wall. No bleeding occurred in any of the vessels 
after application of the maximal voltage (150) provided by the 
Grass St imulator (P-4). Norma l venules and arterioles were not 
broken, and hemorrhage was not produced. In 4 of 63 vessels 
tested, the vessel wall was broken and immediately sealed at 
both ends without hemorrhage. This phenomenon was termed 
11 e lectrocoagulation 11 • The results of the microelectrode test 
are shown in Tables 7 and 8. 
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Hematological and Bone Marrow Findings 
B. Splenectomized Hamsters 
33 
Fourteen hamsters of either sex, weighing 75 to 100 grams, 
were splenectomized. Blood determinations were made before 
splenectomy and at regular intervals thereafter. The results 
are recorded in Table 9 . The animals adjusted well and no 
mortality occurred during the period of observation. The ham-
sters were active from the second day after splenectomy . The 
effects of splenectomy in the hamster were similar to those 
reported previously in guinea pigs , r abbits , dogs, and mice 
(Miller et al, 1942; Bedson , 1924). Within a period of 48 
hours, slight decreases occurred in the red cell counts and 
hemoglobin values. The white cell and reticulocyte counts 
were not a~fected appreciably . The p l atelet counts increased 
gradually, reaching a peak at the 4th to 6th day and returning 
to normal (presplenectomy) values on the 14th to 18th day. 
Platelet emboli were frequent in the circulation through the 
cheek pouch (Fig . 15 ) . The polymorphonuclear-lymphocyte ratio 
was reversed during a two week period after splenectomy, but 
returned to normal by the third week . Increases were found 
in polychromatophilia and target cells, but no Howell- Jolly 
bodies were seen. 
The bone marrow was not affected appreciably by splenectomy. 
The megakaryocytes were unchanged in morphology but increased 
slightly in numbers . The red cell series were increased for a 
period of one week after splenectomY. The white cell series 
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exhibited normal maturation . No unidentifiable cells were found . 
Coagulation Factors and Vascular Fragility 
The bleeding time , coagulation time, and vascular fragility 
(negative pressure , snake venom , and microelectrode tests) were 
within normal limits in splenectomized hamsters . Increased 
numbers of white cells were found adhering to the endothelium 
in the cheek pouch, and the venules exhibited an increased 
tendency for thrombus formation after stimulation with a micro-
electrode . No bleeding was produced in 13 venules and 11 
arterioles by stimulation with a microelectrode (Table 14) . 
C. Immuno-thrombocytopenic Purpura 
Thrombocytopenic purpura was produced in hamsters by 
injection of antiplatelet serum (1-2 ml) into the femoral vein 
(Fig. 7). Depending upon the dose, spontaneous petechiae and 
ecchymoses were observed in the cheek pouch and in almost all 
the organs of the body (Fig . 16 and Table 11) . ~Vhen anti-
platelet serum was injected by other routes (subcutaneous, 
intra-muscular, intraperitoneal or intracardiac) similar re-
sults were obtained. Intravenous doses in excess of 2 . 0 ml 
were lethal, usually producing instantaneous death. Hemor-
rhagic lesions and clumped red blood cells were found in 
histological preparations of the various organs. Fluid 
effusions were common in the peritoneal cavity, but rare in 
the pleural space. Bleeding from the gums and mucous membranes 
of the nose and mouth were seen frequently . The urine and 
feces were usually bloody . 
Hematological and Bone Marrow Findings 
Phenomenal changes occurred immediately after intravenous 
administrat ion of antiplatelet serum. The platel~ts were re-
duced precipitously to p ractically zero level within a few hours 
a fter injection of a potent antiplatelet serum. The red cell 
and hemoglobin values dropped to about 50% before death, p rob-
ably due to bleeding a t va rious sites in the body. Prior to 
injection, the antiplatel et serum was carefully a dsorbed and 
tested in vitro for possible anti-red cell effects. Smears 
of per i pheral blood showed marked anisocytosis and poikilo-
cytosis after 24 hours, and increased polychroma tophilia in 
almos t a ll animals. The various kinds of white cells were not 
a ffecte d . Platelets we re conspicuousl y absent or rarely seen 
on blood smears. 
The bone marrow (Fig . 17) was hypocellular to norma-
cellular. The megakaryocytes were rounded, smaller in size, 
and appeared imma ture. No evidence of platelet production 
was seen, and the cytoplasm was not granular. These striking 
changes were identical with those described in human idiopathic 
thrombocyto penic purpura (Stefanini, 1953). 
Coagulation Factors and Vascular Fragility 
Various tests for he morrhagic diathesis were performed in 
the hamsters g iven antiplatelet serum, and a bnormalitie s were 
seen in the bleeding time, clot . retra ction, a nd fragility of 
the vessel wall. The coagula t ion derangements were presumably 
due to the decrease in platelets in the circulation. 
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The bleeding times (Fig. 18 and Table 12) were uniformly 
increased to longer than 240 seconds, as compared with 
109 i 19 seconds in normal hamsters. It was necessary to 
stop the hemorrhage at the end of 240 seconds because of the 
small blood volume in the hamsters. Hemostasis was accom-
plished by means of an elastic rubber band placed on the tail. 
Clot retraction determinations were made on all the ham-
sters treated with antiplatelet serum. Very poor clot re-
traction (fragile clot) occurred, and frequently none at all . 
Consequently, the retraction of a clot is one of the functions 
of the platelets (Budtz-Olsen, 1951). 
In hamsters with a delay in gross manifestations of pur-
pura, the vascular fragility was determined by the snake 
veno~ test. Profuse formation of petechiae occurred in 30 
minut e s to one hour a fter injection of moccasin venom between 
the layers of the cheek pouch. There was no need to use the 
te s t on hamsters given 2 .0 ml of antiplatelet serum because 
of extensive purpura after 24 hours . 
The microelectrode test was applied at 4 hours and 24 
hours to hamsters previously injected with 2 .0 ml of anti-
platelet serum by femoral canulatiDn (Fig . 7). Another group 
of hamsters were given 2 .0 ml of antiplatelet serum in 2 
increments of 1.0 ml each on alternate days . Ten hamsters 
were used in the "4- hour group" (Table 15). A total of 43 
venules and 25 arterioles of varying sizes were tested by 
microelectrode stimulation. The bubble threshold (Fig. 9) 
J6 
varied between 1.5 and 3 volts. A threshold for constriction 
(Fi g . 10) was found consistently for the arterioles, but not 
for a ll the venules, undoubtedly because of the i rregul ar dis-
tribution of neuro-muscular elements on the venules and veins 
(Lutz et a l, 1950). A thrombosis threshold was observed at 
voltages between 10 and 30, but the thrombus so formed was 
easily embolized and probably very 11 soft 11 • The fragility 
threshold at 4 hours was like that of norma l hamsters (Fig .ll), 
a nd the antiplatelet effect on the vessel wall ha d not occurred 
at this time. Vascular rupture at 150 volts occurred in only 
one medium-sized venule (Table~), but no bleeding was seen. 
Spontaneous petechiae were not found in the cheek pouch at 4 
hours, a lthough definite reduction in p latelet count and in-
crease in bleeding time had occurred. Compensatory me chanisms 
are presumably effective at this time. 
More p ronounced effects were seen at 24 hours in hamster s 
injected intra venously with 2.0 ml of antiplatelet serum. The 
cheek pouch , g eneral skin, and mucous membranes exhibited 
spontaneous petechiae and ecchymoses. Bleeding wa s seen in 
almost all the organs of the body {Table 11). 
In preparation for microsco p ic observa tions on the blood 
ves s els in the cheek pouch, difficulties were encountered in 
exposing the sing le membrane, beca use profuse bleeding re-
sulted from cutt ing the membrane. The hemorrhage was controlled 
by application of heated pins. The rnicroelec trode test was 
~pplied as described previously. White cell sticking to the 
endothelium was very rarely seen. Thrombus formation wa s 
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completely absent at the site of stimulation except in four 
cases ('Iable 16) where a slight iendency existed ("tempora ry 
platelet accumulation"). These ob servat ions were correlated 
with the lowered platelet counts. The fragility threshold 
of the blood ves sels was altered significantly. A total of 
43 venules of varying diameter (Table 16) and 25 arterioles 
in 10 hamsters were test ed with the microele ctrode. Vessel 
rupture and bleeding was demonstrable (F i g . 19) after single 
shock stimulation of 60 to 150 volts. As many as 29 venules 
were fragile at voltages below 150. "Electrocoagula tion" h•a.s 
frequently seen. The arterioles were fragile also , and 8 be-
came hemorrhagic fro~ s ingle shocks of less than 150 volts. 
Three hamsters were given a total of 2 .0 ml of antiplatelet 
serum in 2 doses of 1.0 ml each on alternate days. On the 
third day the effects (Table 17) resembled those of the group 
given 2.0 ml in one dose. Death occurred on the third day. 
Thus the microelectrode test demonstrated very definitely that 
in immunothrombocytopenic purpura, the vessel wall will break 
at voltages which are normally resisted. 
Splenectomized hamsters were given 2.0 ml of ant i platelet 
serum at two days after the operation, and the microelectrode 
test was applied (Table 18). The vascular fragility was in-
creased in spite of the previous splenectomy. Consequently, 
splenectomy had no protective influence on the vessel wall 
even though the platelet count was elevated. 
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The antiplatelet serum was prepared by repeated injections 
of hamster platelets into r abbits, and the serum so obtained 
we s used to produce purpura in hamsters. Therefore, control 
experiments were necessary with 2.0 ml of normal rabbit serum 
injected into hamsters . No abnormalities were found in the 
bleeding mechanism . Spontaneous petech iae were absent. The 
platelet counts, bleeding times, coagulation times (Table 13), 
and results with snake venom te s t were all normal . Congestion 
was seen occasionally in the blood vessels of the cheek pouch. 
It was concluded, t herefore , that the effects observed in 
hamsters treated with antiplatele t serum were antigenic and 
not merely the result of injection of heterologous serum 
~ se. 
Experimental Results with Dextran 
Since Groenwall and Ingleman (1943) published the blood 
volume expanding pronerties of intravenous infusions of 6 per 
cent dextran, extensive clinical trials has been made with this 
substance. Thorsen (1949) was among the first to report the 
11 reactions" that occurred with all types of dextran in use in 
Sweden. Wilkinson (1953) reported "reactions" in normal human 
volunteers, during or soon after dextran infusions. The re-
actions were characterized by urticaria and vasomotor in-
stability and were anaphylactoid in nature. Carbone et al, 
(1954) described, for the first time, a defect in the hemo-
static mechanism and increased bleeding time in human volunteers 
infused with 6 per cent dextran. The clinical significance of 
this defect has been unsolved to date. 
In the following experiments various types of dextran in 
6 per cent solutions were injected intravenously in the hamster, 
and the effects on the blood, bone marrow, and circulation in 
the cheek pouch have been determined. The names of the manu-
facturers and the lot numbers for each dextran solution were 
as follows: R.K. Laros, Lot no. 13301A; Commercial Solvent 
Corporation (Expandex), Lot no. 575; Benger Laboratories 
(Dextraven) Lot no. 4635; and Cutter Laboratories, Lot no. 
58195E. Comparative studies were made with a 3.5 per cent 
solution of Polyvinylpyrolidon (P.V.PJ in saline, supplied by 
Schenley Laboratories (Lot no. 1009113). 
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Changes in Blood and Bone Marrow after Dextran Infusions 
The changes produced by dextran in blood vary with the amount 
injected and perhaps with the type of dextran used . The initial 
changes result from hemodilution and are consistent irrespective 
of the source of dextran. 
A total of 38 hamsters were given 10 ml of various types of 
dextran as shown in Table I . The only effects on the peripheral 
blood counts at 24 hours after injection were those of hemo-
dilution. The hemoglobin values and the total red cell counts 
were reduced temporarily, but the total white cell counts and 
platelet numbers remained unchanged . Blood smears stained by 
the Wright and Giemsa method were normal. The red cells were 
normal at 24 hours, except for polychromatophilia. Slight 
anemia was indicated by hypochromia of the red cells (Fig. 20). 
This effect was reversible within 2 to 3 weeks. The white cells 
were not affected qualitatively . The platelets showed a ten-
dency toward clumping . These findings were constant for all the 
plasma expanders, but absent in saline controls. In order to 
evaluate the possible role of a sudden increase in volume as a 
factor contributing to the bleeding defect, control experiments 
were made using 10 ml of mammalian Ringer's solution. This 
amount of saline was equal to the total blood volume (Fulton 
and Kagan, 1955) in a hamster of 100 gm, body weight . Subse-
quently, the blood smears, bone marrow, coagulation factors, 
and vascular fragilities were studied. No significant changes 
occurred. 
Temporary hemodilution caused by dextrans and a decrease 
in erythrocyte counts have been observed by other workers 
(Bloom, 1951; Humphrey-Long, 1951; Taylor, 1951). A lowering 
of the plasma protein concentration has been reported following 
dextran infusions (Thorsen, 1950). 
The bone marrow preparations were normocellular with a 
7 to 1 ratio of white cells to red cells (Fig. 21). The meg-
akaryocytes exhibited normel maturation and granularity of 
cytoplasm. The erythrocyte series were normal. An occasional 
increase was seen in lymphoid elements (Fig. 21), although 
this may not have been significant. 
Coagulation Factors in Hamsters Infused with Dextran 
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Eleven hamsters were injected with 10 ml of Laros dextran 
and tested for clotting times a.t 24 hours. The clotting time was 
134 i 40 seconds as compared with that of normal hamsters 
(143 i 50 seconds). As shown in Table 2, the difference was not 
statistically significant. 
Six hamsters were given 6 ml of Laros dextran and the blood 
was tested for clotting times. The value of 140 i 29 seconds 
was not significantly different from that in the control group. 
The bleeding times were taken by the technique described 
and recorded on filter paper. 
Significant increases were observed with a.ll types of 
dextran except Expandex. Physiological saline (10 ml) was in-
jected as a control for possible chang es due to expansion of 
the vessel wall. The control group did not show significant 
increases in bleeding time (Table 3). The greatest extension 
of bleeding time was produced by Laros dextran (Fig. 22). 
Injections of 3 ml in 5 hamsters extended the bleeding time to 
210 ~ 29 seconds which as significantly long er than the normal 
bleeding time of 109 i 19 seconds. In 16 hamsters injected 
with 6 ml of Laros dextran, the bleeding time increased to 
205 i 53 seconds. Injections of 10 ml in 11 hamsters pro-
duced a bleeding time longer than 240 seconds. The differences 
between 10 ml and 6 ml and bet~reen 10 ml and 3 ml were signi-
ficant (Fisher test). 
Bleeding time determinations for other types of dextran 
were as follows: Cutter (10 rnl), 175 i 63 seconds; Benger 
(10 ml), 142 i 52 seconds; and Expandex (10 rnl), 124 i 28 
seconds. Expandex produced no significant effect. 
Prothrombin time determinations were made in 6 hamsters 
at 24 hours after injection with 6 rnl of Lares dextran and the 
prothrombin time (10.6 i 0.3 seconds) wa s not significantly 
different from that of normal hamsters (10.5 i 0.2 seconds). 
No increase occurred with 10 ml (Table 4). Prothrombin time 
tests were made in Lares-treated hamsters only. No signifi-
cant differences occurred in clot retraction following in-
jection of 10 ml of Laros dextran (Table 5). 
Tests for Vascular Fragility 
The negative p ressure test wa s applied to the cheek pouch 
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of 11 hamsters injected with 10 ml of Leros dextran. No signi-
ficant increases were found in petechiae as compared with controls. 
The moccasin snake venom test was applied extensively to 
dextran-treated hamsters (Table 6). The cheek pouches were 
everted for testing at intervals of 24 hours and 4 days after 
injection of dextran. The number of petechiae were counted 
under a binocular dissecting microscope at 1 hour and 2 hours. 
The data were treated statistically. A total of 81 hamsters 
tested with various types of dextran. 
The results indicated that only Laros dextran (Table 6) 
produced significant increases in petechial susceptibility 
as shown by the snake venom test. P . V. P . did not produce 
appreciable increases in petechial formation. 
The microelectrode test for vascular fragility and hemo-
static defect was applied to hamsters treated with the Laros 
type of dextran only. A total of 12 hamsters were infused with 
dextran. Four hamsters were given 10 ml and observed after 2 
hours , and 24 hours; and 8 hamsters were injected with 6 ml 
every day for 3 days and examined on the fourth day . The re-
sults with 10 ml at 2 hours are shown in Table 20. Eight 
venules and sixteen arterioles of various sizes were tested 
with a single shock stimulus of varying strength (1 to 150 
volts). The "bubble threshold" was 1.5 to 3 volts, and the 
constriction threshold was 10 to 30 volts. if.hite thrombo-
embolism was seen consistently at voltages varying from 10 to 
30 (Table 20). White cell sticking occurred , and pavement of 
white blood cells was observed occasionally on the endothelial 
lining of venules (Fig.2:5). The fragility threshold was normal 
and did not show hemorrhage even at 150 volts, although electro-
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coagulation occurred. 
At 24 hours, 11 venules and 11 arterioles of different 
sizes were stimulated with single shocks, at varying voltages. 
The bubble threshold and the constriction thresholds were 
similar to those determined at 2 hours, but the thrombus thres-
hold was not consistent (Table 21). The fragility threshold 
was decrreased in 8 venules and profuse bleeding occurred ob-
literating the field during microscopic examination. 
The microelectrode test was applied on the fourth day 
after daily injection with Laros dextran for 3 days (Table 19). 
A total of 19 venules and 25 arterioles of varying diameter 
were stimulated. The bubble threshold, the constriction thres-
hold, and the thrombus threshold were normal, but the fragility 
threshold was significantly lower. Eighteen blood vessels ex-
hibited decreases in fragility threshold and manifested profuse 
hemorrhage at voltages less than 150 (Table 19). Consequently, 
hamsters injected with Laros dextran showed consistently 
lowered fragility thresholds after 24 hours and 3 days. 
In Vivo Vascular Changes in the Cheek Pouch 
For analysis of possible effects of increases in bl~od 
volume per se, control experiments were done with injections of 
10 ml of mammalian Ringer's solution. Transitory changes were 
observed due to hemodilution. The slow flow and pale pouch 
soon returned to normal. The microalectrode test did not show 
abnormal findings. Transient arteriolar vasoconstriction was 
observed (Fig. 25) within 15 minutes after intravenous injection 
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of dextran (3 ml to 10 ml). The nonspecific tendency of leuko-
cytes to adhere to the vessel wall was a consistent finding. 
Leukocytic adhesiveness was minimal after three days and dis-
appeared gradually within 3 to 4 weeks. Thrombus formation 
was normal or slightly increased. No spontaneous petechiae 
were seen. 
Direct observations of the blood vessels in the cheek 
pouch of the hamster show a rich vas cular pattern. The normal 
blood flow has been observed in arterioles (Fig. 24), venules 
(Fig. 23) and capillaries and recorded in a Kodachrome motion 
picture film (Fulton, Lutz, Desai and Berman, 1954). The flow 
in venules is characterized by the rolling of white blood 
cells along the walls of the vessel (Fig . 23). The arteriolar 
flow is faster and does not permit observation of individual 
formed elements . When the circulation was slowed down, in-
dividual platelets were seen in the blood stream and photo-
graphed . 
In hamsters treated with anti-platelet serum, spontaneous 
petechiae were seen in the everted cheek pouch, varying in 
number from 25-100 and in size from 5 to 50 microns. The dis-
tribution of petechiae was greater in the mus cular area than 
in the thin, transparent portion. When observed under the 
microscope at 200x to 900x, the petechiae were found along the 
walls of venules and next to venular junctions. 
During the preparation of a single layered membrane, 
difficulty was encountered because of the bleeding tendency 
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induced by antiplatelet serum. Profuse hemorrhages resulted 
even though care was taken to avoid an excessively vascular 
area of the pouch. Such bleeding was checked by pressure 
from moist cotton held with forceps or by application of 
heated pins . The venular and arteriolar flow was normal 
except for the terminal state. 
Within 12 hours after splenectomy, no significant 
vascular changes were seen in the transilluminated cheek 
pouch, except for a decrease in rate of flow. At 12 to 
24 hours, an increase in emboli and white cell sticking 
were commonly observed. The increase persisted from the 
third day until the sixth or seventh. During this time, 
spontaneous thrombus formation was commonly seen. Large 
thrombi exhibited phenomenal canalization and embolization. 
At 12 to 16 days slight increases were observed in white cell 
sticking. The in vivo observations are in agreement with the 
results of in vitro examination of the blood. 
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DISCUSSION 
From the existing knowledge of hemostasis and hemodynamics, 
blood circulates in a closed system of vessels, the smallest 
units of which may be seen under the microscope as thin-walled 
capillaries separating the blood from the tissue fluid. The 
intravascular elements are transported in this system, and an 
effective but invisible exchange occurs constantly between the 
intravascular and extravascular fluids. Under normal conditions, 
the formed elements do not pass through the walls of the blood 
vessels. In the absence of frank bleeding from rupture of the 
vessel wall, egression of the formed elements would require 
passage through the inter-endothelial cement and the perivascular 
sheath, resulting from a defect in either or both. The oc-
currence of a defect in the coagulation mechanism does not 
necessarily produce spontaneous bleeding. Furthermore, it is 
evident from the clinical literature that the platelets may be 
maximally depressed without the appearance of hemorrhagic 
lesions. Consequently, a third factor, damage to the vessel 
wall, was postulated as important in the pathogenesis of hemo-
stasis (Ledingham and Bedson, 1915; Leonard and Falconer, 1940; 
Spaet, 1952). This concept has gained increasing support, but 
no convincing evidence has been found in the literature for a 
defect in the blood vessel wall. 
Three different defects in the mechanisms of hemostasis 
have been described in hamsters with experimental purpura in-
duced by immunological means: first,a reduction in platelets; 
second, a prolonged bleeding time; and third, an increase in 
vascular fragility. 
The bleeding ~efect in hamsters produced by infusion with 
dextran is not associated with a platelet deficiency or dis-
turbance in coagulation factors. However, the vascular 
fragility is increased as shown by the microelectrode and 
moccasin venom tests. A decrease in p latelets per se will 
not result in petechiae and ecchymoses. Instead, a weaknes s 
in the vessel wall permits diapedesis of the cellular elements 
to form petechiae. 
The diapedesis of erythrocytes and the mechanism of 
formation of petechiae has been shown by Arendt, et al (1953) 
in a motion picture record of cell-by-cell egression from the 
venular walls into the tissues. According to Fulton, et al 
(1955) the petechiae are formed at the venular junctions, 
either by a defect in the cement or in the perivascular 
sheath. It is conceivable that an alteration in the cement 
substance might lead to edema. Since edema was not found in 
hamsters treated with antiplatelet serum, the defect is per-
haps located in the endothelial cell p roper or in the peri-
vascular sheath. With dextran, the vessel wall defect may be 
due to a "toxic" action on the cells of the endothelium. 
The precise comp onent involved and the exact nature of the 
damage to the wall remain to be solved. 
By means of the microelectrode test, direct evidence has 
been presente d for the first time in support of the concept 
that a defect in the vascular wall may be a major f a ctor in 
hemorrhagic diathesis. 
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Summary and Conclusions 
(1) Previous hematological values for the peripheral blood and 
the bone marrow of the golden hamster (Mesocricetus auratus) 
have been confirmed, and new data for reticulocyte counts, 
morphology of the blood elements and characteristics of the 
bone marrow have been reported. 
(2) Standard coagulation tests, namely, clotting time, pro-
thrombin time, clot retraction, and fibrinolysis test 
have been applied to the hamster. Special tests for 
yascular fragility and for hemostatic function have been 
used also, namely, negative pressure test, moccasin snake 
venom, and microelectrode. 
(3) Kodachrome motion pictures have been taken of blood flow 
and intravascular elements in the hamster cheek pouch in 
normal and patholgical conditions. 
(4) Splenectomy has been accomplished in the hamster with no 
postoperative difficulties, and subsequent changes in 
blood, bone marrow, coagulation mechanism, and in vivo 
vascular effects in the cheek pouch have been studied. 
After splenectomy, the platelet counts were increased and 
white thromboembolism was more prevalent. The formation , 
canalization, and embolization of thrombi haYe been re-
corded on motion picture film. 
(5) Experimental purpura was produced in the hamster by ad-
ministration of entiplatelet serum obtained from rabbits 
previously injected with hamster platelets. Spontaneous 
petechiae and generalized bleeding were observed. The 
derangement occurring in the hemostatic mechanism has 
been analyzed by study of the changes in blood, bone 
marrow, and fragility of vasular walls as shown by the 
response to the microelectrode test and snake venom test. 
The cause of bleeding has been postulated as a double 
defect resulting from the decrease of platelets in the 
circulation and an alteration in the integrity of the 
vessel wall or perivascular supporting sheath. 
(6) Splenectomy did not protect the hamster from experimental 
purpura following injection of antiplatelet serum. 
(7) In control experiments, rabbit serum was injected in ham-
sters without abnormalities in blood values and with no 
significant changes in the circulation in the cheek pouco. 
(8) In view of the recently described bleeding defect produced 
by dextran in man, varioas dextran solutions have been 
evaluated for effects upon vascular fragility end the hemo-
static mechanism in the hamster. The Laros product caused 
the greatest increase in fragility of the vessel wall. 
Changes in blood, bone marrow, and coagulation mechanism 
were not greet. In vivo effects of dextran infusions on 
circulation in the cheek pouch have been photographed. 
"'7 
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Increased white cell adhesiveness, thrombus formation, and 
transient vasoconstriction were observed after infusion with 
dextran. Evidence has been presented to show that the 
bleeding defect produced by dextran is due to an alteration 
in the integrity of the vessel wall or perivascular sheath. 
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("\ ~able 1. - Hematological Values in Hamsters at Twenty-four \II 
Hours after Plasma Expansion 
Type of Normal Values (Expandex) Plasma expander P .V. P . 
determination {44 Hamsters~ ~LAROS) (BENGER) ~CUTTER) 
FiBC (XlOfl ) 6 .8,t). 2 4.7i_0.8 4.l_il.3 4.56i.l.3 5. O_iO. 9 4 .82i_l.2 
WBC (Xlo3 ) 5.72i_l.5 6.3_i2.1 7.li_l.8 4.54i.l.6 4 .90i_l.O 5.3i.0.8 
Platelets (Xl05 ) 8.1 i.l.l 7.8_i2.2 7. 2_il. 6 ?.O_il.8 6 .5i_l. 3 6.o_i2.o 
Hemoglobin (gm/%) 15.8i.2.1 11. O_il.9 l0.8i_2.5 10. 5.t). 2 11. 2i_l. 7 12 . 5i2 .3 
Hemoglobin <%) 
Reticulocyte(.%) 2.5il.2 3.l_il.2 3.8_il.4 2.0_i0.7 1.5i.0/8 3.7_i2.0 
Polymorphs <%) 30i_6 55i.ll 30i.l2 65i.7. 5 48i_o.5 37i.ll 
Lymphocytes (%) 6li_7.5 35i.8 60_il0.5 34_i6.9 52i_ll.O 62i.7 .5 
Monocytes <1) 3. Oi.O. 5 2 .0i.l 4i_l. 5 li.O 2i_0.5 4_il.5 
Eosinophil s (f ) 1.2i_l.O 2.0il li.O 0.5i.O 3i.l.2 2_i0.5 
Basophil s <%) None None None None None None 
Blood smear: 
Anisocytosis 1) - l ) - 1) - 1) I 1) Poikilocytosis 2) - 2) - 2 > I 2) I 2) -Polychromatophilia 3) I 3) I 3) I 3) I 3) I Targe t cell 4) I 4) I 4) I 4) .t 4 > I Spherocytosis 5) - 5) - 5) - 5) - 5 ) i. Pl a telet clumping 6) I 6) I 6) I 6) I 6) I 
.:::}-
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Table 2. - Coagulation Times 1n Hamsters at Twenty-four 
Hours after Plasma Expansion 
Plasma Number of Coagulation Time Significant difference as 
Expander Hamsters (Seconds) Compared with Controls 
No expander 
(untreated controls) 
10 ml. of 6% dextran 
(Laros) 
6 ml. of 6% dextran 
(Laros) 
15 
11 
6 
143 i_ 50 
134 i 40 no 
140 i 29 no 
Table 3. - Bleeding Times in Hamsters at Twenty-four 
Hours after Plasma Expansion 
Plasma Expander Number of Bleeding Time Significant 
Hamsters (seconds) difference 
no expander 
(untreated controls) 36 109 I 12 
10 ml. of saline 6 121 1_26 no 
(saline controls) 
6 ml. of 6% Dextran 
(Lares) 16 205 I 53 yes 
10 ml. of 6% Dextran 
(Leros) 11 greater than 24010 yes 
3 ml. of 6% Dextran 
(Lares) 5 210 I 29 yes 
10 ml. Expande:x 7 124 I 28 no 
10 ml . P . V. P. 7 164 I 58 yes 
10 ml. of 6% Dextran 
(Cutter) 8 175 I 63 yes 
10 ml. of 6% Dextran 
(Benger's) 5 142 I 52 yes 
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Table 4. - Prothrombin Time in Hamsters at Twenty-four 
Hours after Plasma EJP ansion 
Plasma Number of Prothrombin Time Significant difference as 
Expander Hamsters (Seconds) Compared with Controls 
No expander 
(untreated controls) 
10 ml. of 6% dextran 
(Laros) 
6 ml. of 6% dextran 
(Laros) 
6 
6 
6 
10.5 I o.2 
10.4 i 0.5 NO 
10.6 j_ 0.) NO 
('._ 
\!"'\ 
Table 5. - Clot Retraction Tests in Hamsters at Twenty-four 
Hours after Plasma Expansion 
Plasma 
Expander 
No expander 
(untreated controls ) 
10 ml. of 6% dextran 
(Laros) 
Number of 
Hamsters 
7 
5 
Amount of serum obtained after 
1 hour in millilitres from lee 
blood 
0.26 :1.. - 0.11 
o. 28 £ - o. o6 
Significant difference 
s Compared with 
Controls 
NO 
Table h .-
Pe techial Susceptibility in Hams ters a ft er Fla srna Expans ion 
(Moccasin Snake Venom Test) 
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Plasma 
Expander 
Number of No. of Petechiae in Significant differences 
Hamsters Cheek Pouch as Compared with Controls 
no expander 
(untrea ted controls) 
10 ml . o f saline 
(sal ine controls) 
6 ml. Laros dextran 
(24 hours) 
6 ml . Laros dextran 
(6 hours) 
3 ml . Laros dextr an 
( 24 hours) 
10 ml. Bengers 
Dext r a ven 
(24 hours) 
10 ml . of 6% dextran 
(Cutter) 24 hours 
1 0 ml. P • V. P • 
(24 hours) 
10 ml . Laros dext ran 
(24 hours) 
10 ml . Expandex 
(24 hours) 
10 ml . of 6% dextran 
(Cutter) 4th day 
10 ml . P .V. P . 
(4th day) 
10 ml. Laros dextran 
(4th day) 
10 ml. Expandex 
(4th day) 
33 
7 
8 
8 
6 
6 
12 
6 
8 
7 
4 
4 
4 
8 
1 hour 2 hours 
7l.f_6 138/ 20 
52-1_13 117-1_29 No 
203.f_l29 Yes 
2361 131 357/_80 Yes 
151-1_50 279/115 Yes 
6l.f_7 123/ 14 No 
87.f 44 191/_100 No 
113/_59 230/_121 No 
293/_107 400.j Yes 
lll.f_34 24l.j_l07 No 
78.f_9 164.j_20 No 
7 51 _23 145-l 27 No 
84,t _14 167f' 27 Yes 
751 27 1781 87 No 
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Table 7. - Microelectrode Stimulation Test(l)in the Hamster Cheek Pouch 
A. Normal Young Hamsters 
Animal Type of Vessel Constriction W. B.C. Threshold Fragility at 
Number and size 2 Threshold Sticking for Thrombus(l50 volts~ (in volts) .3 (in volts) (in volts) 
1 V(S) 11.0 11.0 NB 
1 V{S) 7.5 7.5 19 NB 
1 V(S) 11.0 11.0 18 NB 
2 V(S) 12.0 19.5 NB 
2 V(S) 13.5 17.0 NB 
2 V(S) 15 15 NB 
3 V(S) 14.5 14.5 NB 
3 V(M) 15.0 15.0 15.0 NB 
3 V(M) 12.5 17.0 17.0 NB 
4 V(M) 18.0 18.0 18.0 NB 
4 V(M) 40 40 EC 140 
4 V(M) 14.5 12.5 NB 
5 V(M) 10.5 10.5 NB 
5 V(JY!) 17.5 17.5 17.5 NB 
5 V(M) 12.5 12.5 NB 
6 V(M) 13.5 14.0 NB 
6 V(M) 12.0 12.0 NB 
6 V(L) 10.5 13.5 13.5 NB 
7 V(L) 11.0 11.0 11.0 NB 
7 V(L) 11.0 15.0 NB 
7 V(L) 11.5 17.0 EC 
8 V(L) 12.5 12.5 12.5 NB 
8 V(L) 13.5 13.5 NB 
8 V(L) 11.5 11.5 NB 
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'rable 7 
Animal Type of Vessel Constriction W. B.C. Threshold Fragility at 
Number and size Threshold Sticking for Thrombus (150 volts) 
(in volts) (in volts) (in volts) 
8 V(L) 11.0 11.0 NB 
8 V(L) 11 11.0 11.0 NB 
9 V(L) 12 12.0 NB 
9 V(L) 12.5 12.5 NB 
9 V(L) 10.5 10.5 NB 
9 V(L) 15.5 15.5 15.5 NB 
10 V(L) 17.0 17.0 17.0 NB 
10 V(L) 11.0 11.0 NB 
10 V(L) 12.0 12.0 12.0 EC 
1 A(S) 7.5 11.0 10.0 NB 
1 A(S) 6 .5 10.5 NB 
1 A(S) 4 .5 11.0 NB 
2 A(S) 8 .0 8.0 NB 
2 A(S) 7.0 10.0 7.0 NB 
2 A(S) 6.5 6.5 NB 
3 A(S) 4 .5 ?.5 NB 
3 A(L) 5 .0 15.0 6.0 EC 
3 A(L) 6 .0 6.0 NB 
4 A(L) ?.0 10.0 ?.0 NB 
4 A(L) 10.0 10.0 NB 
4 A(L) 6 .0 6 .0 NB 
5 A(L) 4 . 5 4.5 NB 
5 A(L) 5 .0 6.0 NB 
5 A(L) ?.0 10.5 10.5 NB 
6 A(L) 4.5 4.5 NB 
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Table 7 
Animal Type of Vessel Constriction W.B.C. Threshold Fragility at 
Number and size Threshold Sticking for Thrombus (150 volts) 
(in volts) (in volts) (in volts) 
6 A(L) 7 7.0 NB 
6 A(L) 5.5 7.5 7.5 NB 
7 A(L) 6.5 9.0 9.0 NB 
7 A(S) 3.5 10.0 10.0 NB 
7 A(S) 4.0 5.5 NB 
8 A(L) 6.0 6.0 NB 
8 A(L) 7.5 11.0 11.0 NB 
9 A(L) 5.5 12.5 12.5 NB 
9 A(L) 4.5 15.0 15.0 NB 
9 A(L) 7.0 17.5 17. 5 NB 
10 A(L) 6.0 8.0 NB 
10 A(L) 5.5 9.0 NB 
10 A(L) 9.0 9.0 NB 
10 A(L) 15.5 15.5 20 NB 
Explanations 
1. Stimulation characteristics: single shocks, duration 
10 milliseconds, and bubble threshold between 1.5-3 volts. 
2. V(S), V( M), V(L), A(S), A(M), signify small (S), medium ( M) , 
or large (L), venule (V) or arterile (A). 
Small vessel= 30 t 5 microns . 
Y! edium vessel = 75Z 7 microns 
Large vessel = 150 i 10 microns 
3. A minus sign (-) indicates no response. 
4. NB=No bleeding, B=Bleeding, EC=Electrocoagulation. 
5. ~ . P . A .= emporary platelet accumulation. 
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Table 8 . - Microelectrode Stimulation Test in the Hamster Cheek Pouch 
B . Normal Old Hamsters 
Animal Type of Vessel Constriction W.B.C. Threshold Fragility at 
Number and size Threshold Sticking for Thrombus (150 volts) 
(in volts) (in volts) (in volts) 
1 V(S) 11.0 11.0 EC 140 
1 V(S) 6.5 6.5 11.5 NB 
1 V(S) 7.0 17.0 17.0 NB 
2 V(S) 11.0 11.0 NB 
2 V(S) 12.0 12.5 NB 
2 V(S) 11.5 11.5 EC 
3 V(L) 10.5 10.5 NB 
3 V(L) 15.0 15.0 15.0 NB 
3 V(L) 11.0 11.0 11.0 NB 
4 V(L) 13.0 15.0 EC 
4 V(L) 14.5 14.5 EC 
4 V(L) 17.0 20.0 NB 
5 V(L) 12.0 19.5 19.5 EC 
5 V(L) 17.0 17.0 17.0 .B 
5 V(L) 30.0 30.0 rB 
5 V(L) 7.5 7.5 NB 
1 A(S) 15.0 15.0 25 . 0 NB 
1 A(S) 14.5 14.5 24.0 NB 
2 A(S) 11.5 11.5 14.5 NB 
3 A{S) 19.5 19.5 19.5 NB 
3 A(L) 11.0 11.0 EC 
4 A(L) 20.0 20.0 20.0 NB 
4 A(L) 20.0 NB 
4 A(L) 10.0 23.0 NB 
Explanations 
See Table 7 - Page 61 
Table 8 
Animal Type of Vessel 
Number and size 
5 A(L) 
5 A(L) 
5 A(L) 
Constriction W. B.C. 
Threshold Sticking 
(in voltsl 'in voltsl 
18.0 
11.0 11.0 
17 .o 17.0 
Expl ana tions 
See Table 7 - Page 61 
62 
Threshold Fragility at 
for Thrombus (1.50 volts) 
{in voltsl 
18.0 NB 
20.0 NB 
17.0 NB 
C"'' 
\() 
Table 9 . -
Type of Values before Values at intervals after Splenectomy 
determination splenectomy 
-
( 14 Hamster:;;)_ 48_ ho11rs 5th_9-_?Y_ :tOt'h day 14th day 
RBC (X 106 ) 6.8 1.. 1.35 5.0 i.. 1.75 5.85 i 1.2 5.75 i.. 1.35 6 .1 1.. 1.2 
BC (X 103) 5 .5? i_o.5 6.32 1.. 0.85 6 .98 i.. 2.1 ?.1 i.. 2.1 6 .1 i.. 0.35 
Platelets (Xlo5) 9.68 i.. 0.35 1.2 i.. 0. 25 2.52 i.. 0.8 1.85 i. 0.62 1.0 i.. 0.65 
Hemoglobin (gm%) 15.5 i.. 4.1 13.2 i 0.62 15.2 i. 0.7 14.5 :L 4.2 14.8 i.. 3 .2 
Reticulocyte (%) 2.5 :L 1. 2 3.2 i.. o. 8 6.5 i.. 0.35 5.0 1.. 2 . 5 3.5 i.. 0. 2 
Polymorphs (%) 30 i. 6 52.5 i.. 11.0 62 .0 i. 17.5 40.0 i.. 11.5 37 i.. 5. 2 
Lymphocyte (%) 61 i.. 7. 5 38.0 1.. ?.2 31 i.. 7.5 57 i.. 5. 2 58.5 i. 6 . 5 
Monocyte (.%) 3.0 i.. 0. 5 1.5 i.. 1. 2 2.0 1.. 1. 5 3.0 i o. 7 3 . 8 i. 0. 2 
Eosinophils (%) 1.8 i. 0. 2 1.0 i. 0. 25 1.8 i. 0.2 1.5 i.. 1.2 4.0 i. 1.5 
Basophils (J{) none none none none none 
Blood smear: 
Anisocytosis 1) - 1) - 1) I 1) I 1) -
Poikilocytosis 2) - 2) I 2) I 2) I 2) -
Polychromatophilia 3) I 3) I 3) I 3) I 3) I 
Target cell 4) I 4) I 4) I 4) I 4) I 
Spherocytosis 5) - 5) - 5) - 5) - 5) -
Platelet clump ing 6) - 6) I 6) I 6) I 6) -
~ 
\0 
* Hematological Values in Hamsters at Twenty-four Hours 
Table 10. - a ft er Antiplatelet Serum (2.0 ml, intravenous) 
Type of 
determination 
RBC (X 106) 
WBC (X 103) 
Pl ate let s (X lOJ) 
Hemoglob i n (gm/%) 
Reticulocyte (%) 
Polymorphs <%) 
Lymphocytes (% ) 
Monocytes (%) 
Eosinophils (%) 
Basophils (%) 
Blood smea r: 
Anisocyto s is 
Po ikilocytos is 
Polychroma tophilia 
Tar get cell 
Spherocytosis 
Pl a telet clumping 
Value s before APS 
~11 Hamsters~ 
7 .1 :L. 1.7 
] . 24 :L. 1.20 
9 . 02 i 0 . 85 
15.5 :L. 4.1 
2 . 5 :L. 1. 2 
30 i. 6 
61 i. 7.5 
3 .0 :L. 0. ] 
1 . 8 i. 0.2 
none 
1) -
2 ) -
3) I 
4) I 
5) -
6) -
Values at 24 Hours 
after APS 
4 .1 :L. 1. 1 
6 .12 :L. 1 . 3 
0 . 67 :L. 0 . 32 
8 . 2 :L. 2 .3 
6 . 8 i. 1.35 
27 :L. 11 
59 i. 14.5 
2.0 i. 1. 2 
2 . 5 :L. 0.5 
none 
1) I 
2 ) I 
3) I 
4 ) I 
5) -
6) -
~ 
'() 
Table 11. - Petechiae or Bleeding seen on gross Post Mortem Examination in the 
Organs of Hamster after 2.0 ml Intravenous Injection of 
Antiplatelet Serum -
Animal Site of 
number injection 
Skin and Cheek pouch Br a in 
nails and gums 
Lungs Heart Liver Stomach Peritoneum 
and 
intestines 
Urine 
end 
feces 
1 II I I - .J .J .J .J .J.J .J 
2 - -
3 .; .; .; - .; .; .; .; .; .; 
4 I __ j_ ___ _ _i _____ __ _ l_ _____ .J. - - I I I 
- -
6 i_ _______ .J _ I _ _ _- I l ... _______ L __ _______ _ .f_ ______ _j_ 
7 I I I l l - - I I I 
8 .J I .J - .; .; I .J .; .J 
- - -
1o I _I___ _ _____ L ________ L I .f__ I___ _L___ I I 
11 .J .J .J - .J I I .J I I 
1. These eleven hamsters a re random animals t aken for post mortem. 
Almost a ll animals with antiplatelet serum showed similar results. 
\0 
\0 
Animal 
number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Table 12. - Effect of Antiplatelet Serum in Hamsters at 24 Hours 
after Intravenous Injection of 2.0 ml 
xl o3 103 Platelet count Platelet count Blea!ng time Spontaneous petechiae 
Before After (minutes) in Cheek pouch 
980 108 I 8 
1,100 23 I 15 
902 47 I 6 
898 34 I 20 
1,23Q 83 I 11 
888 97 I 23 
909 31 I 33 
921 20 I 13 
1,213 66 I 7 
1,108 40 I 3 
1.050 53 I 11 
24 
48 
48 
48 
48 
30 
48 
48 
48 
48 
48 
{'-
\() 
Table 13. - Effect of Rabbit Serum in Hamsters at 24 Hours 
after Intravenous Injection of 2.0 ml 
Cheek Pouch Platelet count Bleeding time Snake Venom 
observations (xlo3) (seconds) Test 
Normal 807 120 Norma l 
Congestion 998 90 Normal 
Normal 1,300 105 Normal 
Normal 1,100 111 Normal 
Normal 1,180 123 Normal 
Clotting 
time 
Normal 
Normal 
Normal 
Normal 
Normal 
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9.ble 14. - Microelectrode Stimulation Test in the Hamster Cheek Pouch 
After 2 Days of Splenectomy 
nimal Type of Vessel Constriction W. B.C. Threshold Fragility 
umber and size Threshold Sticking for Thrombus at 
{in volts~ {in voltsl {in volts~ {150 v.ol ts} 
1 V(S) 11.0 11.0 NB 
1 V(S) 7.5 7.5 19 NB 
1 V(S) 11.0 11.0 18 NB 
2 V( S ) 12.0 19.5 NB 
2 V(S) 13.5 17.0 NB 
2 V(S) 15 15 NB 
3 V(S) 14.5 14.5 NB 
3 V( M) 15.0 15.0 15.0 NB 
3 V(M) 12.5 17.0 17.0 NB 
4 V(M) 18.0 18.0 18.0 NB 
4 V(M) 40 40 EC 140 
4 V(M) 14.5 12.5 NB 
5 V{M) 10.5 10.5 NB 
5 V( M) 17.5 17.5 17.5 NB 
5 V( M) 12.5 12.5 NB 
6 v (!•1) 13.5 14.0 NB 
6 V(M) 12.0 12.0 NB 
6 V(L) 10.5 13.5 13.5 NB 
7 V(L) 11.0 11.0 11.0 NB 
7 V(L) 11.0 15.0 NB 
7 V(L) 11.5 17.0 EC 
8 V(L) 12.5 12.5 12.5 NB 
8 V(L) 13.5 13.5 NB 
8 V(L) 11.5 11.5 NB 
Explanations: See Table 7 - Page 61. 
Table 1 5 . - Microelectrode Stimulation Test in Hamsters Treated with 
2 .0 ml I . V. injection of Antiple telet Serum 
(4 hour Observat ion) x200 
Animal Type of Vessel Constriction W. B. C. Threshold Fr agility 
Number end size Threshold St icking for Thrombus at 
1 
1 
2 
2 
3 
3 
4 
4 
5 
5 
5 
6 
6 
7 
7 
8 
8 
1 
1 
2 
2 
10 
(in volts) (in volts) (in volts) (150 volts) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S ) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(M) 
V( M) 
V( M) 
V(M) 
v { I>:) 
V(f>:) 
V(M) 
6 .5 
11.0 
7.5 
10.5 
9 .5 
13.5 
11.0 
12.5 
7.0 
11.5 
11.0 
14.0 
6.5 
9 .5 
11.5 
11.0 
7.5 
23.0 
10.5 
14.5 
9.5 
13.5 
23.0 
32 .0 
17.0 
12.5 
19,5 
11.5 
19.5 
30.0 
Expl anations: See Table 7 - Page 61. 
19.5 
11.5 
11.0 
23 .0 
10;5 
14.5 
17.0 
11.0 
13.5 
11.0 
23 .0 
32.0 
17 .0 
12 . .5 
11.0 
11.5 
19.5 
11.5 
23.0 
30 .0 
EC 
NB 
NB 
NB 
NB 
EC 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
B 
NB 
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Table 15. -
Animal Type of Vessel Constriction W. B. C. Threshold Fragility 
Number and size Threshold Sticking for Thrombus at 
(in volts) (in volts) (in volts) (150 volts) 
10 V(M) 13.5 13.5 NB 
10 V(M) 31.0 NB 
9 V(L) 18.0 18.0 18.0 NB 
9 V(L) 11.0 11.0 NB 
2 V(L) NB 
2 V(L) 14.0 14.0 31.0 NB 
3 V(L) 11.5 20.0 NB 
3 V(L) 13.0 25 .0 NB 
3 V(L) 12.5 NB 
1 A( M) 6 . 5 7.5 NB 
2 A ( ~ ) 4 . 5 NB 
3 A(M) 7.0 11.0 20.0 NB 
4 A(M) 8 . 0 11 .5 NB 
4 A(M) 6.5 9 . 5 NB 
5 A(M) 5 .0 21 .5 NB 
5 A(L) 3.5 11 . 5 27.5 NB 
6 A(L) 4.0 7 . 5 7-5 NB 
6 A(L) 7.0 11.0 NB 
7 A(L) 10.0 10.0 EC 
7 A(L) 8.0 9 . 5 NB 
8 A(L) 6 . 5 NB 
8 A(L) 4.5 14.5 14.5 NB 
8 A(L) 6 .0 10.0 10.0 NB 
Explanations: See Table 7 - Page 61 . 
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Table 15. -
Animal Type of Vessel Constriction W. B.C . Threshold Fragility 
Number and size Threshold Sticking for Thrombus at 
{in volts~ ~in volts~ (in volts~ (150 volts} 
9 A(L) 3.5 19 . 5 EC 
9 A(L) 4 . 5 )0 . 0 NB 
10 A(L) 6 . 0 NB 
Explanations : See Table 7 - Page 61. 
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Table 16 . - Microelectrode Stimulation Test in Hamsters Treated with 
2.0 rnl I.V. injection of Antiplatelet Serum 
Animal 
Number 
1 
1 
1 
2 
2 
2 
3 
3 
3 
3 
4 
4 
5 
5 
5 
6 
6 
7 
7 
7 
8 
8 
9 
9 
(24 hour Observation) 
Type of Vessel Constriction 
and size Threshold 
V(S) 
V(S) 
V(S} 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S ) 
V(S) 
V(S) 
V(S) 
V(S) 
V(S) 
(in volts) 
9 .5 
11.5 
17.0 
11.5 
19.0 
30.5 
11.0 
18.0 
17.5 
33 .0 
90 .0 
W. B.C. Threshold Fragility 
Sticking for Thrombus at 
(in volts) (in volts) (150 volts) 
40 
T . P . A. 11.5 
140 
? 
T . P . A. 19.0 
110 
B 60 
B 100 
B 110 
NB 150 
B 80 
B 150 
B 140 
B 150 
B 80 
B 95 
EC 150 
EC 150 
B 140 
B 140 
B 120 
B 110 
NB 150 
B 150 
B 110 
B 9 0 
B 80 
EC 150 
NB 150 
B 100 
Explana tions: See Table 7 - Page 61 . 
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Table 16. -
Animal Type of Vessel Constriction W. B.C. Threshold Fragility 
Numbe r and size Threshold Sticking for Thrombus at 
(in volt s ) (in volts) (in volts) (150 volts) 
1 V( M) 11.0 B 130 
1 V(M) 19.0 B 150 
10 V(M) B 120 
10 V( M) 12.5 13.0 EC 150 
10 V(N) 19.5 B 150 
2 V( N) T . P . A. 40 B 140 
2 V( M) NB 150 
3 V(L) 23.0 23 . 0 EC 150 
3 V(L) 11.5 B 120 
4 V(L) 110 B 130 
4 V(L) B 130 
5 V(L) NB 150 
5 V(L) 19 .5 NB 150 
1 V(L) NB 150 
1 V(L) 18 .0 100 B 100 
6 V(L) 11.0 B 80 
6 V(L) 120 ? EC 150 
7 V(L) B 150 
8 V(L) 10.5 NB 150 
8 A(S) ? NB 150 
9 A(S) ? NB 150 
9 A(S) 10.0 EC 150 
10 A(S) 11.0 B 150 
10 A(S) 5. 0 NB 150 
Exp lanations: See Table 7 - Page 61 
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Table 16 . -
Animal Type of Vessel Constriction W. B.C. Threshold F r agility 
Nu mbe r and size Threshold Sticking for Thrombus a t 
{in volts~ ~in volts) ~in volts) {150 volts2 
1 A(S) 18.5 50 ? B 110 
1 A(S) 21 .0 30 NB 150 
2 A(S) 17.5 20 . 5 B 120 
2 A(S) 13.5 EC 150 
3 A(S) 9 .5 NB 150 
3 A(L) 11.0 NB 150 
4 A(L) 17.0 45.0 NB 150 
4 A(L) 11.0 NB 150 
5 A(L) 4.5 B 135 
5 A(L) 9 • .5 T.P.A. 80 B 140 
6 A(L) 7.0 14.7 B 150 
6 A(L) 4.0 B 110 
7 A(L) 3.5 EC 150 
7 A(L) 4.5 NB 150 
8 A(L) 9 .0 NB 150 
8 A(L) 11.0 150 NB 150 
9 A(L) 8 .5 150 EC 150 
9 A(L) 7.0 ? B 150 
10 A(L) s.o 100 B 140 
10 A(L) 4.5 NB 150 
Explanations: See Table 7 - Page 61. 
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rable 17. - Electrode Stimulation Test kn Hamsters Treated with Total 
2 .0 ml. of Antiplatelet Serum , I.V. 1.0 ml. alternate day 
(Observations on 4th Day) 
Animal Type of Vessel Constriction t.J . B.C. Threshold Fragility 
Number and Size Threshol d Sticking for Thrombus at 
{in volts} ~in volts} ~in volts} {150 volts} 
1 V(S) 40 40 B 100 
1 V(S) 50.0 B so 
2 V(S) 11.0 11 NB 
2 V(S) NB 
2 V(L) 40 40 EC 
3 V(L) 30 30 30 EC 
3 V(L) 28.0 NB 
3 V(L) NB 
3 V(L) 23 .0 B 120 
3 V(L) 45.0 45 NB 
2 V(L) 50 NB 
2 V(L) NB 
2 V(L) 23.0 EC 140 
1 A(.N) 25.0 70 EC 
1 A(M.) 17.0 50 NB 
1 A(~) 11.0 110 110 NB 
2 A(L) 11.5 NB 
2 A(L) 3.5 B 130 
2 A(L) 9.0 NB 
3 A(L) 7.0 140 B 150 
3 A(L) 5.0 NB 
3 A(L) 4.5 NB 
Explanations: See Table 7 - Page 61. 
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Table 18. - Electrode Stimulation Test on Splenectomized Hamsters 
Injected with Antiplatelet Serum 2.0 ml I.V. on the 
3rd Day after Operation. (Observation after 24 hours 
of Injection of Antiplatelet Serum) 
Animal Type of Vessel Constriction vJ .B.C. Threshold Fragility 
Number and size Threshold Sticking for Thrombus at 
(in volts~ (in volts~ (in volt s} (150 volts} 
1 V(S) 11.0 11.0 NB 
1 V(S) 15.0 B 100 
1 V(S) 9.0 9 .0 150 NB 
2 V( M) 9.5 9.5 110 NB 
2 V( M) 7.5 17.0 NB 
2 V(M) 6.5 10.0 B 90 
2 V( M) 14.5 60 B 150 
3 V(L) 11.0 50 NB 
3 V(L) 13.0 40 NB 
3 V(L) 7.5 47.5 NB 
3 V(L) 9.0 50.0 NB 
3 V(L) 11.0 11.0 NB 
3 V(L) 19.0 19.0 NB 
1 A(M) 11.0 35.0 NB 
1 A(M) 17.5 17.5 19.0 NB 
1 A(M) 10.0 21.0 EC 
1 A(M) 12.0 B 100 
2 A(L) 11.0 16.5 B 80 
2 A(L) 10.0 17.0 21 .5 B 110 
2 A(L) 4.5 NB 
3 A(L) 7-5 11.0 EC 
3 A(L) 11.0 70.0 B 100 
3 A(L) 8 .5 8 .5 50.0 B 140 
3 A(L) 6.0 6.0 35.0 B 150 
Explanations: See Table 7 - Page 6 
able 19. - Microelectrode Stimulation Test in Hamsters Treated with 
Daily Intravenous Injections of 6 .0 ml Dextran (Laros) 
(Observations on the 4th Day) 
nimal 
umber 
Type of Vessel 
and size 
Fragility 
at 
77 
Constriction 
Threshold 
(in volts) 
Threshold 
for Thrombus 
(in volts) (150 volts) 
1 
1 
1 
1 
2 
2 
2 
2 
2 
3 
3 
3 
4 
4 
4 
4 
5 
5 
5 
6 
6 
6 
6 
6 
V(S) 
V(S) 
V(S) 
V(S) 
v ( 1\1 ) 
V(M) 
V(M) 
V(M) 
V(M) 
V(M) 
V( H) 
V(M) 
V( M ) 
V(L) 
V(L) 
V(L) 
V(L) 
V(L) 
V(L) 
V(L) 
V(L) 
V(L) 
V(L) 
V(L) 
11.0 
14.0 
17.0 
13.0 
12.5 
14.5 
19.0 
11.0 
13.5 
17.0 
30.0 
27.0 
18.0 
19.0 
11.0 
14.0 
20.0 
14.0 
40 
100 
13.0 
12.5 
14.5 
30.0 
32.0 
47.0 
80.0 
18.0 
44.5 
31.0 
27.0 
18.0 
13.0 
18.0 
19.0 
17.0 
Explanations: See Table 7 - Iage 61 
B 100 
B 80 
B 120 
EC 
EC 120 
NB 
NB 
NB 
NB 
NB 
EC 140 
B 100 
B 120 
B 90 
NB 
B 
NB 
B 70 
NB 
NB 
B 120 
B 110 
EC 
Table 19. -
Animal Type of Vessel Constriction 
Nu mber and size Threshold 
(in volts) 
1 A(S) 5.0 
1 A(S) 5.5 
1 A(S) 7.5 
1 
2 
2 
2 
2 
3 
3 
3 
3 
3 
4 
4 
4 
4 
5 
5 
5 
6 
6 
6 
6 
A( S ) 
A( M) 
A( M) 
A( M) 
A( M) 
A( M) 
A( M) 
A( ) 
A(L) 
A(L) 
A(L) 
A(L) 
A(L) 
A(L) 
A(L) 
A(L) 
A(L) 
A(L) 
A(L) 
A(L) 
A(L) 
8.5 
11.0 
7.0 
4.5 
5-5 
7.0 
9.0 
9 .5 
10.5 
1 0 .0 
6 
3.5 
11.0 
8 .5 
7.0 
6.5 
6 .0 
Threshold 
for Thrombus 
(in volts) 
15.0 
17.0 
11.0 
15.5 
1 9 .0 
11.0 
17.0 
15.0 
13.5 
11.5 
17.0 
19.0 
11.0 
18.5 
19.0 
21.0 
Exp l a na tions: See Table 7 - Page 61. 
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Fra gility 
a t 
(150 volts) 
B 150 
B 100 
NB 
NB 
EC 
EC 130 
NB 
NB 
NB 
NB 
B 100 
B 120 
B 150 
B 140 
NB 
NB 
NB 
B 80 
B 20 
B 90 
NB 
NB 
NB 
~ble 20. - Microelectrode Stimulation Test in Hamsters Treated with 
Single Intravenous Injections of 10 m1. Dextran (Lares). 
(Observations after Two Hours) 
79 
1imal Type of Vessel Constriction W. B.C. Threshold Fragility 
lmber and size Threshold 
1 
1 
1 
2 
2 
3 
3 
4 
4 
1 
1 
1 
2 
2 
2 
3 
3 
3 
3 
4 
4 
4 
4 
V(S) 
V(S) 
V(S) 
V(S) 
V(L) 
V(L) 
V(L) 
V(L) 
V(L) 
A(M) 
A(M) 
A(J't1) 
A(M) 
A(M) 
A(f"') 
A(M) 
A(L) 
A(L) 
A(L) 
A(L) 
A(L) 
A(L) 
A(L) 
(in volts} 
10.0 
14.5 
17.5 
11.0 
13.5 
13.0 
19.0 
30.0 
27.0 
20.0 
15.5 
15.0 
13.5 
17.5 
18.0 
Sticking for Thrombus at 
(in volts) (in volts} (150 volts) 
10.0 
10.0 
14.5 
lr/.5 
11.0 
12.0 
10.0 
14.0 
13.0 
18.0 
19.0 
30.0 
17.0 
27.0 
20.0 
15.5 
15.0 
11.0 
10.5 
13.5 
17.5 
18.5 
9 .0 
30.0 
20.0 
21.0 
7-5 
11.0 
19.0 
14.5 
14.0 
13.5 
18.0 
19.0 
30.0 
17.0 
30.0 
45.0 
50 .0 
42.0 
17.0 
18.0 
19.0 
21.0 
18.5 
19.0 
NB 
NB 
NB 
NB 
EC 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
EC 140 
NB 
NB 
NB 
NB 
NB 
NB 
NB 
EC 
Explanations: See Table 7 - Page 61. 
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able 21. - Microelectrode Stimulation Test in Hamsters Treated with 
Single Intravenous Injections of 10 ml . Dextran (Laros). 
(Observations after 24 hours) 
n imal Type of Vessel Constriction Threshold Fragility 
umber and size Threshold for Thrombus a t 
(in volts) (in volts) (150 volts) 
1 V(S) NB 
1 V(S) 11.0 NB 
2 V(S) 13.0 NB 
2 V(S) 17.0 40 B 100 
2 V(L) 60 B 80 
3 V(L) ,... 30 B 110 
3 V(L) 14.5 33.5 B 150 
4 V(L) 17.0 27.5 NB 
4 V(L) 9.0 NB 
4 V(L) 10.5 EC 130 
1 V(L) NB 
1 A( M) NB 
1 A(M) 30.0 80.0 B 150 
2 A( M) B 150 
2 A( M) B 140 
2 A(M) 11.5 NB 
2 A(M) 17.5 NB 
3 A(M) 13.0 110 NB 
3 A(L) 14.5 NB 
3 A(L) NB 
3 A(L) 19.0 75.0 NB 
4 A(L) B 120 
4 A(L) 18.0 NB 
Explanations: See Table 7 - Page 61. 
Fig. 1. Plastic dish used for microscopic observations 
on the hamster cheek pouch. 
Fig . lA The cheek pouch pulled out, and pinned ready 
for microscopic observations. 
81 
Fig . 2. Peripheral blood smear of a normal hamster 
stained by method of Wright and Giemsa , showing 
the morphology of red cells , white cells, and 
platelets x900 . 
82 
Fig . 3. Bleeding tiffie record in a normal hamster using 
filter-paper technique. 
Fig . 4. Bone marrow smear of a normBl hamster stained 
by method of Wright and Giemsa, showing normal 
maturation of megakaryocytes, red cells, and 
white cells. 
84 
Fig . 5. Snake venom test showing the injection of 
venom between two layers of the pouch . 
85 
Fig . 6. Negative pressure test sh owing 11 cup 11 positioned 
on the pouch, mercury manometer, and the dis-
secting microscope . 
• 
86 
.. -· ~--
Fig. 7. Femoral cannulation, showing the cannula in 
position . 
(By courtesy of Mr . Kenneth Arendt) 
87 
Fig . 8 . Equipment used in the microelectrode test 
and in cinephotomicrography. 
88 
Fig . 9 . Microelectrode test showing the 11 bubble threshold 11 
x900 . 
89 
Fig . 9A Microelectrode test showing the electrode in 
position to the vessel wall. x900. 
90 
Fig . 10. Microelectrode test showing the "Gonstriction 
Threshold" . x900. 
91 
Fig. 11. f.icroelectrode test showing inability to break the 
normal vessel wall even at high voltage single 
shock stimulation of 150 volts. 
Electrocoagulation as described in the test can 
x900. 
Fig . 19. Lowered fragility threshold with antiplatelet serum, 
shown by microelectrode test. Bleeding occurred at 
low voltages. Compare with normal in Fig. 11. 
92 
, 
. Fig. 12. Megakaryocyte in bone marrow of normai hamster, 
showing granular cytoplasm, complex multilobed 
nucleus, and a few platelets around the cell. 
X900. 
~ 
0\ 
Fig . 13. Petechiae produced by snake venom test. x35 Note the size and 
shape of petechiae and compare with Fig. 14 . 
Fig . 14. Spontaneous uetechiae caused by antip1ete1et serum (2 . 0 m1 
intravenous) after 24 hours. Note the size and shape of 
petechiae . 
ig. 15. Clump s of platelets in peripheral blood of hamster 
6 days after splenectomy (Platelet count 2.3 million 
per cubic millimeter) . x900. 
95 
Fig . 16. Gross view of hamster injected intravenously with 
2 .0 ml antiplatelet serum. Postmortem showed 
bleeding phenomenon in almost all organs and 
hemorrhagic ascitis. 
96 
Fig . 17 . Bone marrow changes in h a msters injected with 
antiplatelet serum . x900. 
91 
Fig . 1 8 . Bleeding time in hzmster~ in ected with anti -
platelet serum . Note the increased bleeding time 
compared to F i g . 3 . 
98 
Fig . 19. Lowered fragility threshold with antiplatelet 
serum , shown by microelectrode test . Bleeding 
occurred at low voltages. Compare with normal 
in Fig . 11 . 
99 
Fig . 20. Peripheral blood after dextran injection 10 ml . 
Laros intravenously - observations made after 
4 days . 
Note hypochromi~ increased polychromatophilia . 
100 
Fig . 21 . Bone marrow changes in hamster injected with 
dextran (Lares 10 m1). Observation after 4 
days . 
101 
102 
Fig . 22. Bleeding time record in a dextran treated hamster . 
Note increased bleeding time compared to Fig . 3 . 
Fig . 23 . Venular flow in normal hamster. xl200 . 
Note the white cell s rolling on the vessel wall. 
(Enlargement from 16 mm . cinephotomlcrographic 
record.) 
103 
Fig . 24. Arteriolar flow in a normal hamster xl200 . 
(Enlargement from 16 mm. cinephotographic 
record) . 
104 
105 
Fig . 25 . Vasoconstriction after dextran treatment. 
Fig. 26. Excessive white cell sticking in hamsters 
treated with dextran. Compare with Fig . 23. 
106 
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Hemorrhagic disorders designated by the term "purpura" 
are usually associated with the appearance of petechiae, ecchy-
moses, and lowered platelet counts. However, the mechanism of 
bleeding a nd the etiolog y remain unsolved. The cheek pouch of 
of the hamster was used in an attempt to determine the cause of 
the bleeding under two conditions: first, in experimental pur-
pura produced by antiplatelet serum prepared by repeated in-
jections of hamster platelets into rabbits, and second, 
following infusion with dextran. 
Peripheral blood counts, bone marrow examinations, 
coagulation tests, and special tests for vascular fragility 
and hemostatic function (negative pressure, snake venom, and 
microelectrode) have been applied to normal hamsters as a 
basis for interpretation in hemorrhagic dia thesis. Microscopic 
observations were made in vivo and recorded on Kodachrome 
motion picture film by means of cinephotomicrog raphic equip-
ment. 
The results of previous blood counts and bone marrow 
examinations have been confirmed and analyzed more critically. 
Detailed observations have been made on the morphology of the 
blood cells in the stained smear and reticulocyte counts have 
been reported for the first time in the hamster. The red cell 
count in the hamster (6.8 + 1.2 miJlion per cu. mm.) is sligh tly 
higher than that in man, and the reticulocyte value is also 
higher (2.5 + 1.2 per cent). The polymorphonuclear and lympho-
cytic values were reversed in the hamster (polymorphs 30 + 6 
per cent, lymphocytes 61 + 7.5 per cent). The peripheral blood 
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smear showed moderate polychromatophilia and occasional target 
cells. The bone marrow of the hamster was more cellular than 
that of man, with a ratio of white cells to red cells of 8!1. 
The coagulation tests we re within limits comparable with those 
for man. 
Three in vivo tests for vascular fragility and hemo-
static function in the hamster cheek pouch were utilized: 
namely, the moccasin venom test (Fulton, Lutz, Shulman, and 
Arendt , in press); the negative pressure test (Shulman , Mode , 
Kagan, and Fulton, Anat. Rec . 118:408, 195ti); and the micro-
electrode test (Fulton, Akers, and Lutz. Blood 8_e- 140, 1953). 
The snake venom test applied to the cheek pouch of the normal 
hamster produced 71 ± 6 petechiae at one hour intervals and 
lJ8 + 20 at the end of two hours. The negative pressure test 
produced from 0 to 4 petechiae at one minute Nith a negative 
pressure of 20 mm . of mercury. The microelectrode test was 
used to evaluate the fragility of blood vessels by stimulation 
of the wall with single faradic shocks. Vasoconstrictio~ oc-
currad at low voltages (threshold, 4 to 10 volt single shock) 
in muscular arterioles and venules. The sphincters were more 
sensitive than other portions of the vascular network. White 
cell sticking and platelet thrombosis occurred at hi~her vol-
tages (10 to JO volts). The vessel wall of normal hamsters 
was resistant even to very high voltages (150 volts). If 
normal vessels were ruptured, the broken ends were sealed 
immediately, probably by "electrocoagulation". The results 
of the microelectrode test were compared in young and "old age" 
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hamsters. No significant differences were obtained except for 
a n increase in white cell adhesiveness in the "old age" group . 
Hamsters of either sex and 7 5 to 100 gra.ms in weight 
were splenectomized. The platelet counts increased daily for 
4 to 6 days after splenectomy and gradually returned to normal 
on the 14th to 18th day . The smear of peripheral blood ex-
hibited increased polychromatophilia , target cells, and clumps 
of platelets, particularly on the 4th to 8th day. Howell-Jolly 
bodies were absent . Changes in the bone marrow were not re-
markable. The microelectrode test for thrombus susceptibility 
revealed a marked tendency for thrombosis, while the fragility 
threshold did not differ from that in normal hamsters. 
Experimental thrombocytopenic purpura in hamsters, 
caused by injection of antiplatelet serum, produced spontaneous 
purpura , ecchymoses and bleeding manifestations in the cheek 
pouch and in almost all organs of the body. The platelet co~nts 
were decreased and the bone marrow showed immature-like amorphic 
megakaryocytes. Bleeding times and clot retraction determinations 
were abnormal. Values for the bleeding time in excess of 240 
seconds v-rere not uncommon (normal bleading time, 109 + 19). The 
snake venom test produced profuse numbers of petechiae within 
one half hour. Stimulation of the blood vessel wall with low 
voltage produced platelet thrombi in normal hamsters. In thrombo-
cytopenic hamsters, thrombus formation and leukocytic sticking did 
not occur even with high voltages. However , the vessel walls were 
fragile and rupture occurred at electric thresholds lower than 
150 volts (60 to 140). These changes were more marked at 24 hours 
after treatment with antiplatelet serum than at two hours. 
Small repeated injections of antiplatelet serum produced 
similar results. 
In control experiments , hamsters were injected with 
serum obtained from normal rabbits and with saline solution . 
The test procedures showed no appreciable deviations from 
normal values. The fragility thresholds were normal. 
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The splenectomized hamsters with elevated platelet 
counts were given antipletelet serum . The fragility threshold 
to electrical stimulation of the vessel wall was lowered and 
hemorrhage occurred at low voltages. Consequently, splenectomy 
and the concomitant increase in numbers of circulating plate-
lets hed no protective effect in expe rimental purpura . 
Recently, detrimental reactions to plasma substitutes 
have been critically evaluated and the dextrans have been re-
ported to cau se a hemostatic defect in human beings. Dextran 
increasea the bleeding time in normal volunteers as well as in 
patients with shock . The exact nature of the bleeding phen-
omenon has not been determined . The precise techniques 
available for the study of hemorrhage in the hamster cheek puuch 
have been used to evaluate the hemostatic defect caused by 
dextran and to observe in vivo the changes occurring in the 
formed elements of the blood end in the characteristics of the 
vessel wall . 
Hematological changes in the hamster after infusion 
with dextran were insignificant except for the effects of 
hemodilution and the clumping of platelets. The results of the 
various coagulation tests (clott ing time, prothrombin time, 
clot retraction, and fibrinolysis test) were within normal 
limits. The bleeding time was prolonged significantly as 
shown by values of more than 240 seconds as compared with 
values of 109 + 19 seconds in normal hamsters. All dextrans 
used in this study (Lares, Cutter) produced an increased 
bleeding time except Expandex. 
The Lares dextran seemed to be more detrimental 
than other types. After injection of Lares, increased numbers 
of leukocytes were adherent to the endothelium at 24 hours and 
during a period of 3 to 4 weeks . The thrombosis threshold was 
increased. The formation, canalization, and embolization of 
thrombi were recorded on Kodachrome motion picture film. The 
frag ility threshold, as tested with microelectrode and also 
snake venom, was lowered. The vascular defect was greater with 
Lares than with other dextrans. 
In conclusion, experimental purpura was produced in 
hamsters by antiplatelet serwn for the first time. The re-
sultant bleeding phenomenon and hemostatic defect was related 
to lowered platelet counts and decreased frag ility of the 
vessel wall. Splenectomy accompanied by increased platelet 
counts was not remedial. The effe~ts of dextran infusions in 
hamsters have been critically evaluated by routine hemato-
log ical tests a nd by special tests for vascular fragility and 
hemostatic function. A defect in the vessel wall was shown 
by the lowered fragility to faradic stimulation. This finding 
provided the basis for a new explanation for the hemostatic 
defect, namely, damag e to the vessel wall. This is in addition 
to the previously known factors of prolonged bleeding time and 
unexpla ined clumping of the platelets. 
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